Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161)
A specialty field of radiology concerned with diagnostic, therapeutic, and investigative use of radioactive compounds in a pharmaceutical form.
The first artificially produced element and a radioactive fission product of URANIUM. Technetium has the atomic symbol Tc, atomic number 43, and atomic weight 98.91. All technetium isotopes are radioactive. Technetium 99m (m=metastable) which is the decay product of Molybdenum 99, has a half-life of about 6 hours and is used diagnostically as a radioactive imaging agent. Technetium 99 which is a decay product of technetium 99m, has a half-life of 210,000 years.
Isotopes that exhibit radioactivity and undergo radioactive decay. (From Grant & Hackh's Chemical Dictionary, 5th ed & McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
The study of the chemical and physical phenomena of radioactive substances.
Unstable isotopes of gallium that decay or disintegrate emitting radiation. Ga atoms with atomic weights 63-68, 70 and 72-76 are radioactive gallium isotopes.
The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph.
Rhenium. A metal, atomic number 75, atomic weight 186.2, symbol Re. (Dorland, 28th ed)
A trace element that is required in bone formation. It has the atomic symbol Sn, atomic number 50, and atomic weight 118.71.
Inorganic compounds that contain TECHNETIUM as an integral part of the molecule. Technetium 99m (m=metastable) is an isotope of technetium that has a half-life of about 6 hours. Technetium 99, which has a half-life of 210,000 years, is a decay product of technetium 99m.
Polonium. A radioactive element that is a member of the chalcogen family. It has the atomic symbol Po, atomic number 84, and the atomic weight of the isotope with the longest half-life (209Po) is 208.98. It decays by alpha-emission.
Organic compounds that contain technetium as an integral part of the molecule. These compounds are often used as radionuclide imaging agents.
Separation systems containing a relatively long-lived parent radionuclide which produces a short-lived daughter in its decay scheme. The daughter can be periodically extracted (milked) by means of an appropriate eluting agent.
An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Techniques for labeling a substance with a stable or radioactive isotope. It is not used for articles involving labeled substances unless the methods of labeling are substantively discussed. Tracers that may be labeled include chemical substances, cells, or microorganisms.
The amount of radiation energy that is deposited in a unit mass of material, such as tissues of plants or animal. In RADIOTHERAPY, radiation dosage is expressed in gray units (Gy). In RADIOLOGIC HEALTH, the dosage is expressed by the product of absorbed dose (Gy) and quality factor (a function of linear energy transfer), and is called radiation dose equivalent in sievert units (Sv).
Unstable isotopes of mercury that decay or disintegrate emitting radiation. Hg atoms with atomic weights 185-195, 197, 203, 205, and 206 are radioactive mercury isotopes.
Unstable isotopes of copper that decay or disintegrate emitting radiation. Cu atoms with atomic weights 58-62, 64, and 66-68 are radioactive copper isotopes.
Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios.
Samarium. An element of the rare earth family of metals. It has the atomic symbol Sm, atomic number 62, and atomic weight 150.36. The oxide is used in the control rods of some nuclear reactors.
Measurement of radioactivity in the entire human body.
The measurement of radiation by photography, as in x-ray film and film badge, by Geiger-Mueller tube, and by SCINTILLATION COUNTING.
Unstable isotopes of indium that decay or disintegrate emitting radiation. In atoms with atomic weights 106-112, 113m, 114, and 116-124 are radioactive indium isotopes.
The spontaneous transformation of a nuclide into one or more different nuclides, accompanied by either the emission of particles from the nucleus, nuclear capture or ejection of orbital electrons, or fission. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
Radiation protection, also known as radiation safety, is the science and practice of protecting people and the environment from harmful ionizing radiation exposure while allowing for the safe medical, industrial, and research uses of such radiation.
Small computers that lack the speed, memory capacity, and instructional capability of the full-size computer but usually retain its programmable flexibility. They are larger, faster, and more flexible, powerful, and expensive than microcomputers.
Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes.
Thiosemicarbazones are organic compounds resulting from the condensation of thiosemicarbazide with a carbonyl group, characterized by the presence of a -NH-CS-NH-CO- functional structure and widely used in chelation therapy due to their ability to form stable complexes with various metal ions.
An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower.
A class of compounds of the type R-M, where a C atom is joined directly to any other element except H, C, N, O, F, Cl, Br, I, or At. (Grant & Hackh's Chemical Dictionary, 5th ed)
A metallic element, atomic number 49, atomic weight 114.82, symbol In. It is named from its blue line in the spectrum. (From Dorland, 28th ed)
A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, cardiovascular and cerebral circulation, brain, thyroid, and joints.
Astatine. A radioactive halogen with the atomic symbol At, atomic number 85, and atomic weight 210. Its isotopes range in mass number from 200 to 219 and all have an extremely short half-life. Astatine may be of use in the treatment of hyperthyroidism.
A nontoxic radiopharmaceutical that is used in RADIONUCLIDE IMAGING for the clinical evaluation of hepatobiliary disorders in humans.
The ratio of radiation dosages required to produce identical change based on a formula comparing other types of radiation with that of gamma or roentgen rays.
Radioactive substances added in minute amounts to the reacting elements or compounds in a chemical process and traced through the process by appropriate detection methods, e.g., Geiger counter. Compounds containing tracers are often said to be tagged or labeled. (Hawley's Condensed Chemical Dictionary, 12th ed)
A gamma-emitting radionuclide imaging agent used primarily in skeletal scintigraphy. Because of its absorption by a variety of tumors, it is useful for the detection of neoplasms.
The total amount of a chemical, metal or radioactive substance present at any time after absorption in the body of man or animal.
Positively charged particles composed of two protons and two NEUTRONS, i.e. equivalent to HELIUM nuclei, which are emitted during disintegration of heavy ISOTOPES. Alpha rays have very strong ionizing power, but weak penetrability.
Radium. A radioactive element of the alkaline earth series of metals. It has the atomic symbol Ra, atomic number 88, and atomic weight 226. Radium is the product of the disintegration of uranium and is present in pitchblende and all ores containing uranium. It is used clinically as a source of beta and gamma-rays in radiotherapy, particularly BRACHYTHERAPY.
Inorganic compounds that contain tin as an integral part of the molecule.
A method of computed tomography that uses radionuclides which emit a single photon of a given energy. The camera is rotated 180 or 360 degrees around the patient to capture images at multiple positions along the arc. The computer is then used to reconstruct the transaxial, sagittal, and coronal images from the 3-dimensional distribution of radionuclides in the organ. The advantages of SPECT are that it can be used to observe biochemical and physiological processes as well as size and volume of the organ. The disadvantage is that, unlike positron-emission tomography where the positron-electron annihilation results in the emission of 2 photons at 180 degrees from each other, SPECT requires physical collimation to line up the photons, which results in the loss of many available photons and hence degrades the image.
'Sugar acids' are organic compounds derived from sugars through various processes, characterized by the presence of both a carboxyl group (-COOH) and a hydroxyl group (-OH) in their molecular structure, often found in food sources like fruits and used in industries such as food, pharmaceutical, and cosmetic.
Organic chemistry methodology that mimics the modular nature of various biosynthetic processes. It uses highly reliable and selective reactions designed to "click" i.e., rapidly join small modular units together in high yield, without offensive byproducts. In combination with COMBINATORIAL CHEMISTRY TECHNIQUES, it is used for the synthesis of new compounds and combinatorial libraries.
A nonmetallic, diatomic gas that is a trace element and member of the halogen family. It is used in dentistry as flouride (FLUORIDES) to prevent dental caries.
Unstable isotopes of yttrium that decay or disintegrate emitting radiation. Y atoms with atomic weights 82-88 and 90-96 are radioactive yttrium isotopes.
Tomography using radioactive emissions from injected RADIONUCLIDES and computer ALGORITHMS to reconstruct an image.
Unstable isotopes of fluorine that decay or disintegrate emitting radiation. F atoms with atomic weights 17, 18, and 20-22 are radioactive fluorine isotopes.
A compound forming white, odorless deliquescent crystals and used as iodine supplement, expectorant or in its radioactive (I-131) form as an diagnostic aid, particularly for thyroid function tests.
Ytterbium. An element of the rare earth family of metals. It has the atomic symbol Yb, atomic number 70, and atomic weight 173. Ytterbium has been used in lasers and as a portable x-ray source.
The application of scientific knowledge or technology to the field of radiology. The applications center mostly around x-ray or radioisotopes for diagnostic and therapeutic purposes but the technological applications of any radiation or radiologic procedure is within the scope of radiologic technology.
An antiseptic with mild fungistatic, bacteriostatic, anthelmintic, and amebicidal action. It is also used as a reagent and metal chelator, as a carrier for radio-indium for diagnostic purposes, and its halogenated derivatives are used in addition as topical anti-infective agents and oral antiamebics.
A rare, metallic element designated by the symbol, Ga, atomic number 31, and atomic weight 69.72.
A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in cardiovascular and cerebral circulation.
Unstable isotopes of cobalt that decay or disintegrate emitting radiation. Co atoms with atomic weights of 54-64, except 59, are radioactive cobalt isotopes.
Imino acids are organic compounds containing a nitrogen atom in their structure, classified as derivatives of amino acids, where the carbon atom adjacent to the carboxyl group is bonded to a nitrogen atom instead of a hydrogen atom, forming a characteristic imino functional group.
Hospital department responsible for the administration and management of nuclear medicine services.
The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose metabolism in various physiological or pathological states including stroke and myocardial ischemia. It is also employed for the detection of malignant tumors including those of the brain, liver, and thyroid gland. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1162)
A nontoxic radiopharmaceutical that is used in the diagnostic imaging of the renal cortex.
Neutral or negatively charged ligands bonded to metal cations or neutral atoms. The number of ligand atoms to which the metal center is directly bonded is the metal cation's coordination number, and this number is always greater than the regular valence or oxidation number of the metal. A coordination complex can be negative, neutral, or positively charged.
Inorganic salts of phosphoric acid that contain two phosphate groups.
A technetium diagnostic aid used in renal function determination.
A guanidine analog with specific affinity for tissues of the sympathetic nervous system and related tumors. The radiolabeled forms are used as antineoplastic agents and radioactive imaging agents. (Merck Index, 12th ed) MIBG serves as a neuron-blocking agent which has a strong affinity for, and retention in, the adrenal medulla and also inhibits ADP-ribosyltransferase.
A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, liver, and spleen.
The observation, either continuously or at intervals, of the levels of radiation in a given area, generally for the purpose of assuring that they have not exceeded prescribed amounts or, in case of radiation already present in the area, assuring that the levels have returned to those meeting acceptable safety standards.
Cell surface proteins that bind somatostatin and trigger intracellular changes which influence the behavior of cells. Somatostatin is a hypothalamic hormone, a pancreatic hormone, and a central and peripheral neurotransmitter. Activated somatostatin receptors on pituitary cells inhibit the release of growth hormone; those on endocrine and gastrointestinal cells regulate the absorption and utilization of nutrients; and those on neurons mediate somatostatin's role as a neurotransmitter.
An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.
Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site.
A technetium imaging agent used to reveal blood-starved cardiac tissue during a heart attack.
Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS.
Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS.
A potent, long-acting synthetic SOMATOSTATIN octapeptide analog that inhibits secretion of GROWTH HORMONE and is used to treat hormone-secreting tumors; DIABETES MELLITUS; HYPOTENSION, ORTHOSTATIC; HYPERINSULINISM; hypergastrinemia; and small bowel fistula.
Radiotherapy where cytotoxic radionuclides are linked to antibodies in order to deliver toxins directly to tumor targets. Therapy with targeted radiation rather than antibody-targeted toxins (IMMUNOTOXINS) has the advantage that adjacent tumor cells, which lack the appropriate antigenic determinants, can be destroyed by radiation cross-fire. Radioimmunotherapy is sometimes called targeted radiotherapy, but this latter term can also refer to radionuclides linked to non-immune molecules (see RADIOTHERAPY).
An amphetamine analog that is rapidly taken up by the lungs and from there redistributed primarily to the brain and liver. It is used in brain radionuclide scanning with I-123.
Use of radiolabeled antibodies for diagnostic imaging of neoplasms. Antitumor antibodies are labeled with diverse radionuclides including iodine-131, iodine-123, indium-111, or technetium-99m and injected into the patient. Images are obtained by a scintillation camera.
A gamma-emitting RADIONUCLIDE IMAGING agent used in the evaluation of regional cerebral blood flow and in non-invasive dynamic biodistribution studies and MYOCARDIAL PERFUSION IMAGING. It has also been used to label leukocytes in the investigation of INFLAMMATORY BOWEL DISEASES.
Tumors or cancer located in bone tissue or specific BONES.
Compounds that contain the radical R2C=N.OH derived from condensation of ALDEHYDES or KETONES with HYDROXYLAMINE. Members of this group are CHOLINESTERASE REACTIVATORS.
"Citrates, in a medical context, are compounds containing citric acid, often used in medical solutions for their chelating properties and as a part of certain types of nutritional support."
Imaging methods that result in sharp images of objects located on a chosen plane and blurred images located above or below the plane.
Any visual display of structural or functional patterns of organs or tissues for diagnostic evaluation. It includes measuring physiologic and metabolic responses to physical and chemical stimuli, as well as ultramicroscopy.
Two-phase systems in which one is uniformly dispersed in another as particles small enough so they cannot be filtered or will not settle out. The dispersing or continuous phase or medium envelops the particles of the discontinuous phase. All three states of matter can form colloids among each other.
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
A technetium imaging agent used in renal scintigraphy, computed tomography, lung ventilation imaging, gastrointestinal scintigraphy, and many other procedures which employ radionuclide imaging agents.
Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes.
Devices or objects in various imaging techniques used to visualize or enhance visualization by simulating conditions encountered in the procedure. Phantoms are used very often in procedures employing or measuring x-irradiation or radioactive material to evaluate performance. Phantoms often have properties similar to human tissue. Water demonstrates absorbing properties similar to normal tissue, hence water-filled phantoms are used to map radiation levels. Phantoms are used also as teaching aids to simulate real conditions with x-ray or ultrasonic machines. (From Iturralde, Dictionary and Handbook of Nuclear Medicine and Clinical Imaging, 1990)
The total amount of radiation absorbed by tissues as a result of radiotherapy.
The use of molecularly targeted imaging probes to localize and/or monitor biochemical and cellular processes via various imaging modalities that include RADIONUCLIDE IMAGING; ULTRASONOGRAPHY; MAGNETIC RESONANCE IMAGING; FLUORESCENCE IMAGING; and MICROSCOPY.
'Iodobenzenes' are aromatic organic compounds consisting of a benzene ring substituted with an iodine atom (I), typically represented by the chemical formula C6H5I.
A system for verifying and maintaining a desired level of quality in a product or process by careful planning, use of proper equipment, continued inspection, and corrective action as required. (Random House Unabridged Dictionary, 2d ed)
The making of a radiograph of an object or tissue by recording on a photographic plate the radiation emitted by radioactive material within the object. (Dorland, 27th ed)
Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity.
The hollow, muscular organ that maintains the circulation of the blood.
The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065)
The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation.
Organic compounds which contain P-C-P bonds, where P stands for phosphonates or phosphonic acids. These compounds affect calcium metabolism. They inhibit ectopic calcification and slow down bone resorption and bone turnover. Technetium complexes of diphosphonates have been used successfully as bone scanning agents.
Experimental transplantation of neoplasms in laboratory animals for research purposes.
Studies determining the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. For drugs and devices, CLINICAL TRIALS AS TOPIC; DRUG EVALUATION; and DRUG EVALUATION, PRECLINICAL are available.
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses.
Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen.
Methods of creating machines and devices.
Tomography using x-ray transmission and a computer algorithm to reconstruct the image.
Tumors or cancer of the PROSTATE.
Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment.
Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM.
The species Oryctolagus cuniculus, in the family Leporidae, order LAGOMORPHA. Rabbits are born in burrows, furless, and with eyes and ears closed. In contrast with HARES, rabbits have 22 chromosome pairs.
The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.
Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are linear polypeptides that are normally synthesized on RIBOSOMES.
Elements of limited time intervals, contributing to particular results or situations.
Antibodies produced by a single clone of cells.
The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments.
Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed.
Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.
Tumors or cancer of the human BREAST.

Cardiac sympathetic activity estimated by 123I-MIBG myocardial imaging in patients with dilated cardiomyopathy after beta-blocker or angiotensin-converting enzyme inhibitor therapy. (1/6785)

Impaired cardiac sympathetic activity can be evaluated by 123I-metaiodobenzylguanidine (MIBG) imaging. METHODS: We studied the significance of MIBG imaging for 24 patients (age 58+/-12 y) with dilated cardiomyopathy (DCM). We compared 12 patients (group A) treated with metoprolol (dose from 30-60 mg/d) with 12 patients treated with angiotensin-converting enzyme (ACE) inhibitors. Patients were studied before treatment, after 5 mo of treatment (only in group A) and after 1 y of treatment. Cardiac MIBG uptake was assessed as the heart-to-mediastinum activity ratio (H/M) and total defect score (TDS) from anterior planar and SPECT MIBG images, which were acquired in 4 h after tracer injection. New York Heart Association (NYHA) class and left ventricular ejection fraction (LVEF) calculated by echocardiography were also assessed. RESULTS: TDS decreased in both groups (in group A, from 30+/-7 through 23+/-9 to 18+/-10; P < 0.01, in group B, from 30+/-6 to 24+/-8; P < 0.01) and H/M was increased in both groups (in group A, from 1.87+/-0.31 through 2.03+/-0.28 to 2.14+/-0.29; P < 0.01, in group B, from 1.82+/-0.28 to 1.94+/-0.26; P < 0.05). But TDS and H/M were more improved in group A than in group B (P < 0.05). LVEF was significantly increased in only group A (from 38+/-6 through 43+/-8 to 49%+/-9%; P < 0.01). NYHA improved in both groups (in group A, from mean 2.5 through 2.1 to 1.8; P < 0.01, in group B, from mean 2.6 to 2.1; P < 0.05) but was more improved in group A than in group B (P < 0.05). CONCLUSION: Cardiac function, symptom and cardiac sympathetic activity evaluated by MIBG images improved after the beta-blocker therapy more than with the treatment that used ACE inhibitors.  (+info)

Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart. (2/6785)

Norepinephrine (NE) reuptake function is impaired in heart failure and this may participate in myocyte hyperstimulation by the neurotransmitter. This alteration can be assessed by 123I-metaiodobenzylguanidine (MIBG) scintigraphy. METHODS: To determine whether the impairment of neuronal NE reuptake was reversible after metoprolol therapy, we studied 18 patients (43+/-7 y) with idiopathic dilated cardiomyopathy who were stabilized at least for 3 mo with captopril and diuretics. Patients underwent, before and after 6 mo of therapy with metoprolol, measurements of radionuclide left ventricular ejection fraction (LVEF), maximal oxygen consumption and plasma NE concentration. The cardiac adrenergic innervation function was scintigraphically assessed with MIBG uptake and release measurements on the planar images obtained 20 min and 4 h after tracer injection. To evaluate whether metoprolol had a direct interaction with cardiac MIBG uptake and release, six normal subjects were studied before and after a 1-mo metoprolol intake. RESULTS: In controls, neither cardiac MIBG uptake and release nor circulating NE concentration changed after the 1-mo metoprolol intake. Conversely, after a 6-mo therapy with metoprolol, patients showed increased cardiac MIBG uptake (129%+/-10% versus 138%+/-17%; P = 0.009), unchanged cardiac MIBG release and decreased plasma NE concentration (0.930+/-412 versus 0.721+/-0.370 ng/mL; P = 0.02). In parallel, patients showed improved New York Heart Association class (2.44+/-0.51 versus 2.05+/-0.23; P = 0.004) and increased LVEF (20%+/-8% versus 27%+/-8%; P = 0.0005), whereas maximal oxygen uptake remained unchanged. CONCLUSION: Thus, a parallel improvement of myocardial NE reuptake and of hemodynamics was observed after a 6-mo metoprolol therapy, suggesting that such agents may be beneficial in heart failure by directly protecting the myocardium against excessive NE stimulation.  (+info)

Sensitivity of [11C]phenylephrine kinetics to monoamine oxidase activity in normal human heart. (3/6785)

Phenylephrine labeled with 11C was developed as a radiotracer for imaging studies of cardiac sympathetic nerves with PET. A structural analog of norepinephrine, (-)-[11C]phenylephrine (PHEN) is transported into cardiac sympathetic nerve varicosities by the neuronal norepinephrine transporter and stored in vesicles. PHEN is also a substrate for monoamine oxidase (MAO). The goal of this study was to assess the importance of neuronal MAO activity on the kinetics of PHEN in the normal human heart. MAO metabolism of PHEN was inhibited at the tracer level by substituting deuterium atoms for the two hydrogen atoms at the alpha-carbon side chain position to yield the MAO-resistant analog D2-PHEN. METHODS: Paired PET studies of PHEN and D2-PHEN were performed in six normal volunteers. Hemodynamic and electrocardiographic responses were monitored. Blood levels of intact radiotracer and radiolabeled metabolites were measured in venous samples taken during the 60 min dynamic PET study. Myocardial retention of the tracers was regionally quantified as a retention index. Tracer efflux between 6 and 50 min after tracer injection was fit to a single exponential process to obtain a washout half-time for all left ventricular regions. RESULTS: Although initial heart uptake of the two tracers was similar, D2-PHEN cleared from the heart 2.6 times more slowly than PHEN (mean half-time 155+/-52 versus 55+/-10 min, respectively; P < 0.01). Correspondingly, heart retention of D2-PHEN at 40-60 min after tracer injection was higher than PHEN (mean retention indices 0.086+/-0.018 versus 0.066+/-0.011 mL blood/ min/mL tissue, respectively; P < 0.003). CONCLUSION: Efflux of radioactivity from normal human heart after uptake of PHEN is primarily due to metabolism of the tracer by neuronal MAO. Related mechanistic studies in the isolated rat heart indicate that vesicular storage of PHEN protects the tracer from rapid metabolism by neuronal MAO, suggesting that MAO metabolism of PHEN leaking from storage vesicles leads to the gradual loss of PHEN from the neurons. Thus, although MAO metabolism influences the rate of clearance of PHEN from the neurons, MAO metabolism is not the rate-determining step in the observed efflux rate under normal conditions. Rather, the rate at which PHEN leaks from storage vesicles is likely to be the rate-limiting step in the observed efflux rate.  (+info)

Enhanced myocardial glucose use in patients with a deficiency in long-chain fatty acid transport (CD36 deficiency). (4/6785)

CD36 is a multifunctional, 88 kDa glycoprotein that is expressed on platelets and monocytes/macrophages. CD36 also has high homology with the long-chain fatty acid (LFA) transporter in the myocardium. Although platelet and monocyte CD36 levels can indicate a CD36 deficiency, they cannot predict specific clinical manifestations in the myocardium of a given person. We examined the hypothesis that a deficiency in LFA transport augments myocardial glucose uptake in patients with a type I CD36 deficiency. METHODS: Seven fasting patients with a type I CD36 deficiency and 9 controls were assessed by cardiac radionuclide imaging using beta-methyl-p-iodophenyl-pentadecanoic acid (BMIPP) as a LFA tracer and by PET with 18F-fluorodeoxyglucose (FDG). RESULTS: None of the patients with a CD36 deficiency showed myocardial uptake of BMIPP. The percentage dose uptake of BMIPP in these subjects was significantly lower than that in normal controls (1.31+/-0.24 versus 2.90+/-0.2; P < 0.005). PET studies revealed that myocardial FDG accumulation was substantially increased in patients with a CD36 deficiency. Quantitative analysis showed that the percentage dose uptake of FDG in patients with a CD36 deficiency was significantly higher than that in normal controls (1.28+/-0.35 versus 0.43+/-0.22; P< 0.01). CONCLUSION: CD36 functions as a major myocardial LFA transporter and its absence may cause a compensatory upregulation of myocardial glucose uptake.  (+info)

Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: a SPECT study using HMPAO and image standardization technique. (5/6785)

This study assessed the accuracy and reliability of Automated Image Registration (AIR) for standardization of brain SPECT images of patients with Alzheimer's disease (AD). Standardized cerebral blood flow (CBF) images of patients with AD and control subjects were then used for group comparison and covariance analyses. METHODS: Thirteen patients with AD at an early stage (age 69.8+/-7.1 y, Clinical Dementia Rating Score 0.5-1.0, Mini-Mental State Examination score 19-23) and 20 age-matched normal subjects (age 69.5+/-8.3 y) participated in this study. 99mTc-hexamethyl propylenamine oxime (HMPAO) brain SPECT and CT scans were acquired for each subject. SPECT images were transformed to a standard size and shape with the help of AIR. Accuracy of AIR for spatial normalization was evaluated by an index calculated on SPECT images. Anatomical variability of standardized target images was evaluated by measurements on corresponding CT scans, spatially normalized using transformations established by the SPECT images. Realigned brain SPECT images of patients and controls were used for group comparison with the help of statistical parameter mapping. Significant differences were displayed on the respective voxel to generate three-dimensional Z maps. CT scans of individual subjects were evaluated by a computer program for brain atrophy. Voxel-based covariance analysis was performed on standardized images with ages and atrophy indices as independent variables. RESULTS: Inaccuracy assessed by functional data was 2.3%. The maximum anatomical variability was 4.9 mm after standardization. Z maps showed significantly decreased regional CBF (rCBF) in the frontal, parietal and temporal regions in the patient group (P < 0.001). Covariance analysis revealed that the effects of aging on rCBF were more pronounced compared with atrophy, especially in intact cortical areas at an early stage of AD. Decrease in rCBF was partly due to senility and atrophy, however these two factors cannot explain all the deficits. CONCLUSION: AIR can transform SPECT images of AD patients with acceptable accuracy without any need for corresponding structural images. The frontal regions of the brain, in addition to parietal and temporal lobes, may show reduced CBF in patients with AD even at an early stage of dementia. The reduced rCBF in the cortical regions cannot be explained entirely by advanced atrophy and fast aging process.  (+info)

Detection of liver metastases from pancreatic cancer using FDG PET. (6/6785)

We evaluated the potential of the glucose analog [18F]fluorodeoxyglucose (FDG) as a PET tracer for the hepatic staging in 168 patients designated for resective pancreatic surgery. METHODS: Metastatic liver disease was confirmed or excluded during surgery or with CT follow-up for at least 6 mo. Proven metastases were then retrospectively identified on preoperative CT (gold standard). Hepatic PET scans of all patients were interpreted blindly. Any focal FDG uptake was considered malignant. Both proven hepatic metastases and suspicious hepatic PET lesions were then compared, lesion by lesion, with CT. Standardized uptake values (SUV) and tumor-to-liver ratios (T/L) were determined for the most intense lesion of each patient. RESULTS: Sensitivity of FDG PET was 68% (15 of 22 patients). The lesion detection rate was 97% (28 of 29 metastases) for lesions >1 cm and 43% (16 of 37 metastases) for lesions < or = 1 cm. Specificity was 95% (138 of 146 patients). Six of eight patients with false-positive results had marked intrahepatic cholestasis (versus 3 of 15 patients with true-positive lesions), one had an infrahepatic abscess and one had a right basal pulmonary metastasis. The SUV and T/L were 4.6+/-1.4 and 2.3+/-1.1, respectively, for malignant lesions and 4.1+/-1.5 and 1.9+/-0.3, respectively, for false-positive lesions and therefore are of limited value. CONCLUSION: FDG PET provides reliable hepatic staging for lesions >1 cm. False-positive results are associated with the presence of marked intrahepatic cholestasis. For lesions < or = 1 cm, FDG PET can define malignancy in 43% of suspicious CT lesions in the absence of dilated bile ducts.  (+info)

L-[1-11C]-tyrosine PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma and skin cancer. (7/6785)

PET with L-[1-11C]-tyrosine (TYR) was investigated in patients undergoing hyperthermic isolated limb perfusion (HILP) with recombinant tumor necrosis factor alpha (rTNF-alpha) and melphalan for locally advanced soft-tissue sarcoma and skin cancer of the lower limb. METHODS: Seventeen patients (5 women, 12 men; age range 24-75 y; mean age 52 y) were studied. TYR PET studies were performed before HILP and 2 and 8 wk afterwards. The protein synthesis rates (PSRs) in nanomoles per milliliter per minute were calculated. After final PET studies, tumors were resected and pathologically examined. Patients with pathologically complete responses (pCR) showed no viable tumors after treatment. Those with pathologically partial responses (pPR) showed various amounts of viable tumors in the resected tumor specimens. RESULTS: Six patients (35%) showed a pCR and 11 patients (65%) showed a pPR. All tumors were depicted as hot spots on PET studies before HILP. The PSR in the pCR group at 2 and 8 wk after perfusion had decreased significantly (P < 0.05) in comparison to the PSR before HILP. A significant difference was found in PSR between the pCR and pPR groups at 2 and at 8 wk (P < 0.05). Median PSR in nonviable tumor tissue was 0.62 and ranged from 0.22 to 0.91. With a threshold PSR of 0.91, sensitivity and specificity of TYR PET were 82% and 100%, respectively. The predictive value of a PSR > 0.91 for having viable tumor after HILP was 100%, whereas the predictive value of a PSR < or = 0.91 for having nonviable tumor tissue after HILP was 75%. The 2 patients in the pPR groups with a PSR < 0.91 showed microscopic islets of tumor cells surrounded by extensive necrosis on pathological examination. CONCLUSION: Based on the calculated PSR after HILP, TYR PET gave a good indication of the pathological outcome. Inflammatory tissue after treatment did not interfere with viable tumor on the images, suggesting that it may be worthwhile to pursue TYR PET in other therapy evaluation settings.  (+info)

Segmental colonic transit after oral 67Ga-citrate in healthy subjects and those with chronic idiopathic constipation. (8/6785)

Measurement of segmental colonic transit is important in the assessment of patients with severe constipation. 111In-diethylenetriamine pentaacetic acid (DTPA) has been established as the tracer of choice for these studies, but it is expensive and not readily available. 67Ga-citrate is an inexpensive tracer and when given orally is not absorbed from the bowel. It was compared with 111In-DTPA in colonic transit studies in nonconstipated control subjects and then in patients with idiopathic constipation. METHODS: Studies were performed after oral administration of 3 MBq (81 microCi) 67Ga-citrate or 4 MBq (108 microCi) 111In-DTPA in solution. Serial abdominal images were performed up to 96 h postinjection, and computer data were generated from geometric mean images of segmental retention of tracer, mean activity profiles and a colonic tracer half-clearance time. RESULTS: There were no differences in segmental retention of either tracer or in mean activity profiles between control subjects and constipated patients. Results in constipated subjects were significantly different from those in controls. The mean half-clearance times of tracer for control subjects were 28.8 h for 67Ga-citrate and 29.9 h for 111In-DTPA in control subjects and 75.0 h for 67Ga-citrate and 70.8 h for 111In-DTPA in constipated patients. CONCLUSION: Oral 67Ga-citrate can be used as a safe alternative to 111In-DTPA for accurate measurement of segmental colonic transit.  (+info)

Radiopharmaceuticals are defined as pharmaceutical preparations that contain radioactive isotopes and are used for diagnosis or therapy in nuclear medicine. These compounds are designed to interact specifically with certain biological targets, such as cells, tissues, or organs, and emit radiation that can be detected and measured to provide diagnostic information or used to destroy abnormal cells or tissue in therapeutic applications.

The radioactive isotopes used in radiopharmaceuticals have carefully controlled half-lives, which determine how long they remain radioactive and how long the pharmaceutical preparation remains effective. The choice of radioisotope depends on the intended use of the radiopharmaceutical, as well as factors such as its energy, range of emission, and chemical properties.

Radiopharmaceuticals are used in a wide range of medical applications, including imaging, cancer therapy, and treatment of other diseases and conditions. Examples of radiopharmaceuticals include technetium-99m for imaging the heart, lungs, and bones; iodine-131 for treating thyroid cancer; and samarium-153 for palliative treatment of bone metastases.

The use of radiopharmaceuticals requires specialized training and expertise in nuclear medicine, as well as strict adherence to safety protocols to minimize radiation exposure to patients and healthcare workers.

Nuclear medicine is a branch of medical imaging that uses small amounts of radioactive material, called radiopharmaceuticals, to diagnose and treat various diseases. The radiopharmaceuticals are taken internally, usually through injection or oral administration, and accumulate in specific organs or tissues. A special camera then detects the radiation emitted by these substances, which helps create detailed images of the body's internal structures and functions.

The images produced in nuclear medicine can help doctors identify abnormalities such as tumors, fractures, infection, or inflammation. Additionally, some radiopharmaceuticals can be used to treat certain conditions, like hyperthyroidism or cancer, by delivering targeted doses of radiation directly to the affected area. Overall, nuclear medicine provides valuable information for the diagnosis, treatment planning, and monitoring of many medical conditions.

Technetium is not a medical term itself, but it is a chemical element with the symbol Tc and atomic number 43. However, in the field of nuclear medicine, which is a branch of medicine that uses small amounts of radioactive material to diagnose or treat diseases, Technetium-99m (a radioisotope of technetium) is commonly used for various diagnostic procedures.

Technetium-99m is a metastable nuclear isomer of technetium-99, and it emits gamma rays that can be detected outside the body to create images of internal organs or tissues. It has a short half-life of about 6 hours, which makes it ideal for diagnostic imaging since it decays quickly and reduces the patient's exposure to radiation.

Technetium-99m is used in a variety of medical procedures, such as bone scans, lung scans, heart scans, liver-spleen scans, brain scans, and kidney scans, among others. It can be attached to different pharmaceuticals or molecules that target specific organs or tissues, allowing healthcare professionals to assess their function or identify any abnormalities.

Radioisotopes, also known as radioactive isotopes or radionuclides, are variants of chemical elements that have unstable nuclei and emit radiation in the form of alpha particles, beta particles, gamma rays, or conversion electrons. These isotopes are formed when an element's nucleus undergoes natural or artificial radioactive decay.

Radioisotopes can be produced through various processes, including nuclear fission, nuclear fusion, and particle bombardment in a cyclotron or other types of particle accelerators. They have a wide range of applications in medicine, industry, agriculture, research, and energy production. In the medical field, radioisotopes are used for diagnostic imaging, radiation therapy, and in the labeling of molecules for research purposes.

It is important to note that handling and using radioisotopes requires proper training, safety measures, and regulatory compliance due to their ionizing radiation properties, which can pose potential health risks if not handled correctly.

Radiochemistry is not strictly a medical definition, but it is a term that is used in the field of nuclear medicine. Radiochemistry is a branch of chemistry that deals with the use of radioisotopes (radioactive isotopes) in chemical reactions. In nuclear medicine, radiochemists prepare and purify radioactive drugs (radiopharmaceuticals) for diagnostic and therapeutic purposes. These radiopharmaceuticals are used in various medical imaging techniques, such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT), to diagnose and monitor diseases, or in targeted therapies to treat cancer. Radiochemistry requires a deep understanding of chemistry, radiochemistry, and radiation safety.

Gallium radioisotopes refer to specific types of gallium atoms that have unstable nuclei and emit radiation as they decay towards a more stable state. These isotopes are commonly used in medical imaging, such as in gallium scans, to help diagnose conditions like inflammation, infection, or cancer.

Gallium-67 (^67^Ga) is one of the most commonly used radioisotopes for medical purposes. It has a half-life of about 3.26 days and decays by emitting gamma rays. When administered to a patient, gallium-67 binds to transferrin, a protein that carries iron in the blood, and is taken up by cells with increased metabolic activity, such as cancer cells or immune cells responding to infection or inflammation. The distribution of gallium-67 in the body can then be visualized using a gamma camera, providing valuable diagnostic information.

Radionuclide imaging, also known as nuclear medicine, is a medical imaging technique that uses small amounts of radioactive material, called radionuclides or radiopharmaceuticals, to diagnose and treat various diseases and conditions. The radionuclides are introduced into the body through injection, inhalation, or ingestion and accumulate in specific organs or tissues. A special camera then detects the gamma rays emitted by these radionuclides and converts them into images that provide information about the structure and function of the organ or tissue being studied.

Radionuclide imaging can be used to evaluate a wide range of medical conditions, including heart disease, cancer, neurological disorders, gastrointestinal disorders, and bone diseases. The technique is non-invasive and generally safe, with minimal exposure to radiation. However, it should only be performed by qualified healthcare professionals in accordance with established guidelines and regulations.

I'm sorry for any confusion, but "Rhenium" is not a medical term. It is a chemical element with the symbol "Re" and atomic number 75. Rhenium is a heavy, silvery-white, metallic element that is highly resistant to corrosion and is used in high-temperature alloys and electronics.

It does not have any direct medical relevance or application as a drug, treatment, or diagnostic tool in human medicine. However, like many other elements, rhenium compounds are being studied for their potential medicinal uses, such as in cancer therapy. But it's important to note that these are still in the research phase and have not yet been approved for use in humans.

I'm sorry for any confusion, but "Tin" does not have a medical definition. Tin is a chemical element with the symbol Sn and atomic number 50. It is a malleable, ductile, silvery-white post-transition metal. It is found in nature mainly as tin oxides and is obtained from the mineral cassiterite through mining and processing.

Tin has no known biological role in humans, animals, or plants, and it is not considered an essential nutrient. Small amounts of tin can be found in some foods and drinking water, but these levels are generally low and not considered harmful. High levels of tin can be toxic to the human body, causing symptoms such as nausea, vomiting, and diarrhea.

If you have any questions about a medical condition or treatment, I would recommend consulting with a healthcare professional for accurate information and guidance.

Technetium compounds refer to chemical substances that contain the radioactive technetium (Tc) element. Technetium is a naturally rare element and does not have any stable isotopes, making it only exist in trace amounts in the Earth's crust. However, it can be produced artificially in nuclear reactors.

Technetium compounds are widely used in medical imaging as radioactive tracers in diagnostic procedures. The most common technetium compound is Technetium-99m (Tc-99m), which has a half-life of 6 hours and emits gamma rays that can be detected by external cameras. Tc-99m is often bound to various pharmaceuticals, such as methylene diphosphonate (MDP) or human serum albumin (HSA), to target specific organs or tissues in the body.

Technetium compounds are used in a variety of diagnostic procedures, including bone scans, lung perfusion scans, myocardial perfusion imaging, and brain scans. They provide valuable information about organ function, blood flow, and tissue metabolism, helping doctors diagnose various medical conditions such as cancer, heart disease, and bone fractures.

It is important to note that technetium compounds should only be used under the supervision of trained medical professionals due to their radioactive nature. Proper handling, administration, and disposal procedures must be followed to ensure safety and minimize radiation exposure.

Polonium is not a medical term, but a chemical element with symbol Po and atomic number 84. It is a rare and highly radioactive metal that occurs naturally in tiny traces as part of the uranium and thorium decay series. There is no known biological role for polonium, and exposure can be harmful or fatal due to its radioactivity. Medical professionals may encounter polonium in the context of radiation safety, nuclear medicine, or forensic investigations.

Organotechnetium compounds are chemical substances that contain carbon-technetium bonds, where technetium is an element with the symbol Tc and atomic number 43. These types of compounds are primarily used in medical imaging as radioactive tracers due to the ability of technetium-99m to emit gamma rays. The organotechnetium compounds help in localizing specific organs, tissues, or functions within the body, making them useful for diagnostic purposes in nuclear medicine.

It is important to note that most organotechnetium compounds are synthesized from technetium-99m, which is generated from the decay of molybdenum-99. The use of these compounds requires proper handling and administration by trained medical professionals due to their radioactive nature.

Radionuclide generators, also known as "radiogenic sources" or "generator systems," are devices that contain a parent radionuclide that decays into a daughter radionuclide. The parent nuclide has a longer half-life than the daughter nuclide and remains within the generator system, while the daughter nuclide is produced continuously through the decay process and can be extracted for use in medical imaging or therapeutic procedures.

The most common type of radionuclide generator used in nuclear medicine is the technetium-99m (^99m Tc) generator, which contains molybdenum-99 (^99 Mo) as the parent nuclide. Molybdenum-99 has a half-life of 66 hours and decays into technetium-99m, which has a half-life of only 6 hours. Technetium-99m emits gamma rays that can be detected by gamma cameras, making it useful for a wide range of diagnostic procedures such as bone scans, lung perfusion imaging, and myocardial perfusion imaging.

Radionuclide generators are typically used in hospitals and medical centers where they can provide a convenient and cost-effective way to produce small quantities of radionuclides for diagnostic or therapeutic purposes. The extracted daughter nuclide can be used immediately, reducing the need for complex shipping and handling procedures associated with other radioactive materials.

Pentetic Acid, also known as DTPA (Diethylenetriaminepentaacetic acid), is not a medication itself but a chelating agent used in the preparation of pharmaceutical products. A chelating agent is a compound that can form multiple bonds with metal ions, allowing them to be excreted from the body.

Pentetic Acid is used in medical treatments to remove or decrease the levels of certain toxic metals, such as lead, plutonium, americium, and curium, from the body. It can be given intravenously or orally, depending on the specific situation and the formulation of the medication.

It is important to note that the use of Pentetic Acid should be under the supervision of a healthcare professional, as it can also bind to essential metals like zinc, calcium, and iron, which can lead to deficiencies if not properly managed.

Isotope labeling is a scientific technique used in the field of medicine, particularly in molecular biology, chemistry, and pharmacology. It involves replacing one or more atoms in a molecule with a radioactive or stable isotope of the same element. This modified molecule can then be traced and analyzed to study its structure, function, metabolism, or interaction with other molecules within biological systems.

Radioisotope labeling uses unstable radioactive isotopes that emit radiation, allowing for detection and quantification of the labeled molecule using various imaging techniques, such as positron emission tomography (PET) or single-photon emission computed tomography (SPECT). This approach is particularly useful in tracking the distribution and metabolism of drugs, hormones, or other biomolecules in living organisms.

Stable isotope labeling, on the other hand, employs non-radioactive isotopes that do not emit radiation. These isotopes have different atomic masses compared to their natural counterparts and can be detected using mass spectrometry. Stable isotope labeling is often used in metabolic studies, protein turnover analysis, or for identifying the origin of specific molecules within complex biological samples.

In summary, isotope labeling is a versatile tool in medical research that enables researchers to investigate various aspects of molecular behavior and interactions within biological systems.

Radiation dosage, in the context of medical physics, refers to the amount of radiation energy that is absorbed by a material or tissue, usually measured in units of Gray (Gy), where 1 Gy equals an absorption of 1 Joule of radiation energy per kilogram of matter. In the clinical setting, radiation dosage is used to plan and assess the amount of radiation delivered to a patient during treatments such as radiotherapy. It's important to note that the biological impact of radiation also depends on other factors, including the type and energy level of the radiation, as well as the sensitivity of the irradiated tissues or organs.

Mercury radioisotopes refer to specific variants of the element mercury that have unstable nuclei and emit radiation as they decay towards a more stable state. These isotopes are often produced in nuclear reactors or particle accelerators for various medical, industrial, and research applications. In the medical field, mercury-203 (^203Hg) and mercury-207 (^207Hg) are used as gamma emitters in diagnostic procedures and therapeutic treatments. However, due to environmental and health concerns associated with mercury, its use in medical applications has significantly decreased over time.

Copper radioisotopes are radioactive isotopes or variants of the chemical element copper. These isotopes have an unstable nucleus and emit radiation as they decay over time. Copper has several radioisotopes, including copper-64, copper-67, and copper-60, among others. These radioisotopes are used in various medical applications such as diagnostic imaging, therapy, and research. For example, copper-64 is used in positron emission tomography (PET) scans to help diagnose diseases like cancer, while copper-67 is used in targeted radionuclide therapy for cancer treatment. The use of radioisotopes in medicine requires careful handling and regulation due to their radiation hazards.

Tissue distribution, in the context of pharmacology and toxicology, refers to the way that a drug or xenobiotic (a chemical substance found within an organism that is not naturally produced by or expected to be present within that organism) is distributed throughout the body's tissues after administration. It describes how much of the drug or xenobiotic can be found in various tissues and organs, and is influenced by factors such as blood flow, lipid solubility, protein binding, and the permeability of cell membranes. Understanding tissue distribution is important for predicting the potential effects of a drug or toxin on different parts of the body, and for designing drugs with improved safety and efficacy profiles.

Samarium is not a medical term itself, but it is a chemical element with the symbol Sm and atomic number 62. It is a silvery-white metallic element that belongs to the lanthanide series in the periodic table.

However, samarium-153 (Sm-153) is a radioactive isotope of samarium that has medical applications. It is used as a therapeutic agent for the treatment of painful bone metastases, particularly in patients with prostate or breast cancer. Sm-153 is combined with a chelating agent to form a complex that can be injected into the patient's bloodstream. The chelating agent helps to ensure that the samarium is distributed throughout the body and is not taken up by healthy tissues. Once inside the body, Sm-153 emits beta particles, which can destroy cancer cells in the bones and relieve pain.

Therefore, while samarium is not a medical term itself, it does have medical applications as a therapeutic agent for the treatment of bone metastases.

Whole-body counting is a non-invasive nuclear medicine technique used for the detection and measurement of radioactivity in the human body. It involves the use of sensitive radiation detectors that can measure the gamma rays emitted by radionuclides present within the body tissues.

The individual lies on a table or sits in a chair with their entire body inside a large detector, which is typically a scintillation camera or a NaI(Tl) crystal. The detector measures the number and energy of gamma rays emitted from the body, allowing for the identification and quantification of specific radionuclides present within the body.

Whole-body counting has several clinical applications, including monitoring patients who have received therapeutic radioisotopes, evaluating the effectiveness of radiation therapy, detecting and measuring internal contamination due to accidental exposure or intentional intake, and assessing the distribution and retention of radionuclides in research studies.

It is important to note that whole-body counting does not provide anatomical information like other imaging techniques (e.g., CT, MRI), but rather offers functional data on the presence and quantity of radioactivity within the body.

Radiometry is the measurement of electromagnetic radiation, including visible light. It quantifies the amount and characteristics of radiant energy in terms of power or intensity, wavelength, direction, and polarization. In medical physics, radiometry is often used to measure therapeutic and diagnostic radiation beams used in various imaging techniques and cancer treatments such as X-rays, gamma rays, and ultraviolet or infrared light. Radiometric measurements are essential for ensuring the safe and effective use of these medical technologies.

Indium radioisotopes refer to specific types of radioactive indium atoms, which are unstable and emit radiation as they decay. Indium is a chemical element with the symbol In and atomic number 49. Its radioisotopes are often used in medical imaging and therapy due to their unique properties.

For instance, one commonly used indium radioisotope is Indium-111 (^111In), which has a half-life of approximately 2.8 days. It emits gamma rays, making it useful for diagnostic imaging techniques such as single-photon emission computed tomography (SPECT). In clinical applications, indium-111 is often attached to specific molecules or antibodies that target particular cells or tissues in the body, allowing medical professionals to monitor biological processes and identify diseases like cancer.

Another example is Indium-113m (^113mIn), which has a half-life of about 99 minutes. It emits low-energy gamma rays and is used as a source for in vivo counting, typically in the form of indium chloride (InCl3) solution. This radioisotope can be used to measure blood flow, ventilation, and other physiological parameters.

It's important to note that handling and using radioisotopes require proper training and safety measures due to their ionizing radiation properties.

Radioactivity is not typically considered within the realm of medical definitions, but since it does have medical applications and implications, here is a brief explanation:

Radioactivity is a natural property of certain elements (referred to as radioisotopes) that emit particles or electromagnetic waves due to changes in their atomic nuclei. This process can occur spontaneously without any external influence, leading to the emission of alpha particles, beta particles, gamma rays, or neutrons. These emissions can penetrate various materials and ionize atoms along their path, which can cause damage to living tissues.

In a medical context, radioactivity is used in both diagnostic and therapeutic settings:

1. Diagnostic applications include imaging techniques such as positron emission tomography (PET) scans and single-photon emission computed tomography (SPECT), where radioisotopes are introduced into the body to visualize organ function or detect diseases like cancer.
2. Therapeutic uses involve targeting radioisotopes directly at cancer cells, either through external beam radiation therapy or internal radiotherapy, such as brachytherapy, where a radioactive source is placed near or within the tumor.

While radioactivity has significant medical benefits, it also poses risks due to ionizing radiation exposure. Proper handling and safety measures are essential when working with radioactive materials to minimize potential harm.

Radiation protection, also known as radiation safety, is a field of study and practice that aims to protect people and the environment from harmful effects of ionizing radiation. It involves various measures and techniques used to minimize or eliminate exposure to ionizing radiation, such as:

1. Time: Reducing the amount of time spent near a radiation source.
2. Distance: Increasing the distance between oneself and a radiation source.
3. Shielding: Using materials that can absorb or block radiation to reduce exposure.
4. Containment: Preventing the release of radiation into the environment.
5. Training and education: Providing information and training to individuals who work with radiation sources.
6. Dosimetry and monitoring: Measuring and monitoring radiation doses received by individuals and populations.
7. Emergency planning and response: Developing plans and procedures for responding to radiation emergencies or accidents.

Radiation protection is an important consideration in various fields, including medicine, nuclear energy, research, and manufacturing, where ionizing radiation sources are used or produced.

I'm sorry for any confusion, but "minicomputers" is not a term that has a medical definition. The term "minicomputer" comes from the field of computer engineering and refers to a class of computers that are smaller and less expensive than mainframe computers, but more powerful and capable than microcomputers or personal computers. They were widely used in the 1960s and 1970s in various industries for tasks such as process control, data acquisition, and small-scale scientific calculations.

If you have any questions related to medical terminology or health sciences, I'd be happy to help!

Iodine radioisotopes are radioactive isotopes of the element iodine, which decays and emits radiation in the form of gamma rays. Some commonly used iodine radioisotopes include I-123, I-125, I-131. These radioisotopes have various medical applications such as in diagnostic imaging, therapy for thyroid disorders, and cancer treatment.

For example, I-131 is commonly used to treat hyperthyroidism and differentiated thyroid cancer due to its ability to destroy thyroid tissue. On the other hand, I-123 is often used in nuclear medicine scans of the thyroid gland because it emits gamma rays that can be detected by a gamma camera, allowing for detailed images of the gland's structure and function.

It is important to note that handling and administering radioisotopes require specialized training and safety precautions due to their radiation-emitting properties.

Thiosemicarbazones are a class of organic compounds that contain the functional group R-NH-CS-N=CNR', where R and R' are organic radicals. These compounds have been widely studied due to their various biological activities, including antiviral, antibacterial, and anticancer properties. They can form complexes with metal ions, which can also exhibit interesting biological activity. Thiosemicarbazones have the ability to act as chelating agents, forming stable coordination compounds with many metal ions. This property has been exploited in the development of new drugs and diagnostic agents.

Positron-Emission Tomography (PET) is a type of nuclear medicine imaging that uses small amounts of radioactive material, called a radiotracer, to produce detailed, three-dimensional images. This technique measures metabolic activity within the body, such as sugar metabolism, to help distinguish between healthy and diseased tissue, identify cancerous cells, or examine the function of organs.

During a PET scan, the patient is injected with a radiotracer, typically a sugar-based compound labeled with a positron-emitting radioisotope, such as fluorine-18 (^18^F). The radiotracer accumulates in cells that are metabolically active, like cancer cells. As the radiotracer decays, it emits positrons, which then collide with electrons in nearby tissue, producing gamma rays. A special camera, called a PET scanner, detects these gamma rays and uses this information to create detailed images of the body's internal structures and processes.

PET is often used in conjunction with computed tomography (CT) or magnetic resonance imaging (MRI) to provide both functional and anatomical information, allowing for more accurate diagnosis and treatment planning. Common applications include detecting cancer recurrence, staging and monitoring cancer, evaluating heart function, and assessing brain function in conditions like dementia and epilepsy.

Organometallic compounds are a type of chemical compound that contain at least one metal-carbon bond. This means that the metal is directly attached to carbon atom(s) from an organic molecule. These compounds can be synthesized through various methods, and they have found widespread use in industrial and medicinal applications, including catalysis, polymerization, and pharmaceuticals.

It's worth noting that while organometallic compounds contain metal-carbon bonds, not all compounds with metal-carbon bonds are considered organometallic. For example, in classical inorganic chemistry, simple salts of metal carbonyls (M(CO)n) are not typically classified as organometallic, but rather as metal carbonyl complexes. The distinction between these classes of compounds can sometimes be subtle and is a matter of ongoing debate among chemists.

Indium is not a medical term, but it is a chemical element with the symbol In and atomic number 49. It is a soft, silvery-white, post-transition metal that is rarely found in its pure form in nature. It is primarily used in the production of electronics, such as flat panel displays, and in nuclear medicine as a radiation source for medical imaging.

In nuclear medicine, indium-111 is used in the labeling of white blood cells to diagnose and locate abscesses, inflammation, and infection. The indium-111 labeled white blood cells are injected into the patient's body, and then a gamma camera is used to track their movement and identify areas of infection or inflammation.

Therefore, while indium itself is not a medical term, it does have important medical applications in diagnostic imaging.

Sodium Pertechnetate Tc 99m is a radioactive pharmaceutical preparation used in medical diagnostic imaging. It is a technetium-99m radiopharmaceutical, where technetium-99m is a metastable nuclear isomer of technetium-99, which emits gamma rays and has a half-life of 6 hours. Sodium Pertechnetate Tc 99m is used as a contrast agent in various diagnostic procedures, such as imaging of the thyroid, salivary glands, or the brain, to evaluate conditions like inflammation, tumors, or abnormalities in blood flow. It is typically administered intravenously, and its short half-life ensures that the radiation exposure is limited.

Astatine is a naturally occurring, radioactive, semi-metallic chemical element with the symbol At and atomic number 85. It is the rarest naturally occurring element in the Earth's crust, and the heaviest of the halogens. Astatine is not found free in nature, but is always found in combination with other elements, such as uranium and thorium.

Astatine is a highly reactive element that exists in several allotropic forms and is characterized by its metallic appearance and chemical properties similar to those of iodine. It has a short half-life, ranging from a few hours to a few days, depending on the isotope, and emits alpha, beta, and gamma radiation.

Due to its rarity, radioactivity, and short half-life, astatine has limited practical applications. However, it has been studied for potential use in medical imaging and cancer therapy due to its ability to selectively accumulate in tumors.

Technetium Tc 99m Lidofenin is a radiopharmaceutical used in nuclear medicine imaging procedures, specifically for hepatobiliary scintigraphy. It is a technetium-labeled compound, where the radioisotope technetium-99m (^99m^Tc) is bound to lidofenin, a liver-imaging agent.

The compound is used to assess the function and anatomy of the liver, gallbladder, and biliary system. After intravenous administration, Technetium Tc 99m Lidofenin is taken up by hepatocytes (liver cells) and excreted into the bile ducts and ultimately into the small intestine. The distribution and excretion of this radiopharmaceutical can be monitored using a gamma camera, providing functional information about the liver and biliary system.

It is essential to note that the use of Technetium Tc 99m Lidofenin should be under the guidance and supervision of healthcare professionals trained in nuclear medicine, as its administration and handling require specific expertise and safety measures due to the radioactive nature of the compound.

Relative Biological Effectiveness (RBE) is a term used in radiation biology and medicine to describe the relative effectiveness of different types or energies of ionizing radiation in causing biological damage, compared to a reference radiation such as high-energy photons (X-rays or gamma rays). RBE takes into account the differences in biological impact between various types of radiation, which can be due to differences in linear energy transfer (LET), quality factor, and other factors. It is used to estimate the biological effects of mixed radiation fields, such as those encountered in radiotherapy treatments that combine different types or energies of radiation. The RBE value for a specific type of radiation is determined through experimental studies that compare its biological impact to that of the reference radiation.

Radioactive tracers are radioisotopes or radiolabeled compounds that are introduced into a biological system, such as the human body, in very small amounts to allow tracking or monitoring of specific physiological processes or locations. The radiation emitted by the tracer can be detected and measured, providing information about the distribution, metabolism, or binding of the compound within the body. This technique is widely used in medical imaging and research for diagnostic and therapeutic purposes. Examples of radioactive tracers include technetium-99m for bone scans, fluorine-18 for positron emission tomography (PET) scans, and iodine-131 for thyroid studies.

Technetium Tc 99m Medronate is a radiopharmaceutical agent used in nuclear medicine for bone scintigraphy. It is a technetium-labeled bisphosphonate compound, which accumulates in areas of increased bone turnover and metabolism. This makes it useful for detecting and evaluating various bone diseases and conditions, such as fractures, tumors, infections, and arthritis.

The "Tc 99m" refers to the radioisotope technetium-99m, which has a half-life of approximately 6 hours and emits gamma rays that can be detected by a gamma camera. The medronate component is a bisphosphonate molecule that binds to hydroxyapatite crystals in bone tissue, allowing the radiolabeled compound to accumulate in areas of active bone remodeling.

Overall, Technetium Tc 99m Medronate is an important tool in nuclear medicine for diagnosing and managing various musculoskeletal disorders.

"Body burden" is a term used in the field of environmental health to describe the total amount of a chemical or toxic substance that an individual has accumulated in their body tissues and fluids. It refers to the overall load or concentration of a particular chemical or contaminant that an organism is carrying, which can come from various sources such as air, water, food, and consumer products.

The term "body burden" highlights the idea that people can be exposed to harmful substances unknowingly and unintentionally, leading to potential health risks over time. Some factors that may influence body burden include the frequency and duration of exposure, the toxicity of the substance, and individual differences in metabolism, elimination, and susceptibility.

It is important to note that not all chemicals or substances found in the body are necessarily harmful, as some are essential for normal bodily functions. However, high levels of certain environmental contaminants can have adverse health effects, making it crucial to monitor and regulate exposure to these substances.

Alpha particles are a type of radiation that consist of two protons and two neutrons. They are essentially the nuclei of helium atoms and are produced during the decay of radioactive isotopes, such as uranium or radon. When an alpha particle is emitted from a radioactive atom, it carries away energy and causes the atom to transform into a different element with a lower atomic number and mass number.

Alpha particles have a positive charge and are relatively massive compared to other types of radiation, such as beta particles (which are high-energy electrons) or gamma rays (which are high-energy photons). Because of their charge and mass, alpha particles can cause significant ionization and damage to biological tissue. However, they have a limited range in air and cannot penetrate the outer layers of human skin, making them generally less hazardous than other forms of radiation if exposure is external.

Internal exposure to alpha-emitting radionuclides, however, can be much more dangerous because alpha particles can cause significant damage to cells and DNA when they are emitted inside the body. This is why inhaling or ingesting radioactive materials that emit alpha particles can pose a serious health risk.

Radium is not a medical term per se, but it is a chemical element with symbol Ra and atomic number 88. It is a radioactive metal that decays spontaneously into radon gas, releasing alpha, beta, and gamma particles in the process. Radium has been used in medicine for various therapeutic purposes, such as in the treatment of cancer, due to its radiation properties.

In a medical context, radium is often used in the form of radium-223 dichloride (Xofigo), which is a radiopharmaceutical agent approved by the U.S. Food and Drug Administration (FDA) for the treatment of castration-resistant prostate cancer that has spread to bones. The radioactive emissions from radium-223 help slow or halt the growth of cancer cells in the bones, reducing pain and other symptoms associated with bone metastases.

It is important to note that radium should only be used under the supervision of trained medical professionals, as it can pose significant health risks if not handled properly due to its radioactive properties.

Tin compounds refer to chemical substances that contain tin (Sn) combined with one or more other elements. Tin can form various types of compounds, including oxides, sulfides, halides, and organometallic compounds. These compounds have different properties and uses depending on the other element(s) they are combined with.

For example:

* Tin (IV) oxide (SnO2) is a white powder used as an opacifying agent in glass and ceramics, as well as a component in some types of batteries.
* Tin (II) sulfide (SnS) is a black or brown solid used in the manufacture of some types of semiconductors.
* Tin (IV) chloride (SnCl4) is a colorless liquid used as a catalyst in the production of polyvinyl chloride (PVC) and other plastics.
* Organotin compounds, such as tributyltin (TBT), are used as biocides and antifouling agents in marine paints. However, they have been found to be toxic to aquatic life and are being phased out in many countries.

Emission-Computed Tomography, Single-Photon (SPECT) is a type of nuclear medicine imaging procedure that generates detailed, three-dimensional images of the distribution of radioactive pharmaceuticals within the body. It uses gamma rays emitted by a radiopharmaceutical that is introduced into the patient's body, and a specialized gamma camera to detect these gamma rays and create tomographic images. The data obtained from the SPECT imaging can be used to diagnose various medical conditions, evaluate organ function, and guide treatment decisions. It is commonly used to image the heart, brain, and bones, among other organs and systems.

Sugar acids are a type of organic acid that are derived from sugars through the process of hydrolysis or oxidation. They have complex structures and can be found in various natural sources such as fruits, vegetables, and honey. In the medical field, sugar acids may be used in the production of pharmaceuticals and other chemical products.

Some common examples of sugar acids include:

* Gluconic acid, which is derived from glucose and has applications in the food industry as a preservative and stabilizer.
* Lactic acid, which is produced by fermentation of carbohydrates and is used in the production of various pharmaceuticals, foods, and cosmetics.
* Citric acid, which is found in citrus fruits and is widely used as a flavoring agent, preservative, and chelating agent in food, beverages, and personal care products.

It's worth noting that while sugar acids have important applications in various industries, they can also contribute to tooth decay and other health problems when consumed in excess. Therefore, it's important to consume them in moderation as part of a balanced diet.

Click chemistry is a term used to describe a group of chemical reactions that are fast, high-yielding, and highly selective. These reactions typically involve the formation of covalent bonds between two molecules in a simple and efficient manner, often through the use of a catalyst. The concept of click chemistry was first introduced by K. B. Sharpless, who won the Nobel Prize in Chemistry in 2001 for his work on chiral catalysis.

In the context of medical research and drug development, click chemistry has emerged as a valuable tool for rapidly synthesizing and optimizing small molecule compounds with therapeutic potential. By using click chemistry reactions to quickly and efficiently link different chemical building blocks together, researchers can rapidly generate large libraries of potential drug candidates and then screen them for biological activity. This approach has been used to discover new drugs for a variety of diseases, including cancer, infectious diseases, and neurological disorders.

One common type of click chemistry reaction is the copper-catalyzed azide-alkyne cycloaddition (CuAAC) reaction, which involves the reaction between an azide and an alkyne to form a triazole ring. This reaction is highly selective and can be carried out under mild conditions, making it a popular choice for chemical synthesis in the life sciences. Other types of click chemistry reactions include the Diels-Alder cycloaddition, the thiol-ene reaction, and the Staudinger ligation.

Overall, click chemistry has had a significant impact on medical research and drug development by enabling the rapid and efficient synthesis of complex small molecule compounds with therapeutic potential. Its versatility and selectivity make it a powerful tool for researchers seeking to discover new drugs and better understand the molecular mechanisms underlying human disease.

Fluorine is not a medical term itself, but it is a chemical element that is often discussed in the context of dental health. Here's a brief scientific/chemical definition:

Fluorine is a chemical element with the symbol F and atomic number 9. It is the most reactive and electronegative of all elements. Fluorine is never found in its free state in nature, but it is abundant in minerals such as fluorspar (calcium fluoride).

In dental health, fluoride, which is a compound containing fluorine, is used to help prevent tooth decay. It can be found in many water supplies, some foods, and various dental products like toothpaste and mouthwash. Fluoride works by strengthening the enamel on teeth, making them more resistant to acid attacks that can lead to cavities.

Yttrium radioisotopes are radioactive isotopes or variants of the element Yttrium, which is a rare earth metal. These radioisotopes are artificially produced and have unstable nuclei that emit radiation in the form of gamma rays or high-speed particles. Examples of yttrium radioisotopes include Yttrium-90 and Yttrium-86, which are used in medical applications such as radiotherapy for cancer treatment and molecular imaging for diagnostic purposes.

Yttrium-90 is a pure beta emitter with a half-life of 64.1 hours, making it useful for targeted radionuclide therapy. It can be used to treat liver tumors, leukemia, and lymphoma by attaching it to monoclonal antibodies or other targeting agents that selectively bind to cancer cells.

Yttrium-86 is a positron emitter with a half-life of 14.7 hours, making it useful for positron emission tomography (PET) imaging. It can be used to label radiopharmaceuticals and track their distribution in the body, providing information on the location and extent of disease.

It is important to note that handling and use of radioisotopes require specialized training and equipment due to their potential radiation hazards.

Emission computed tomography (ECT) is a type of tomographic imaging technique in which an emission signal from within the body is detected to create cross-sectional images of that signal's distribution. In Emission-Computed Tomography (ECT), a radionuclide is introduced into the body, usually through injection, inhalation or ingestion. The radionuclide emits gamma rays that are then detected by external gamma cameras.

The data collected from these cameras is then used to create cross-sectional images of the distribution of the radiopharmaceutical within the body. This allows for the identification and quantification of functional information about specific organs or systems within the body, such as blood flow, metabolic activity, or receptor density.

One common type of Emission-Computed Tomography is Single Photon Emission Computed Tomography (SPECT), which uses a single gamma camera that rotates around the patient to collect data from multiple angles. Another type is Positron Emission Tomography (PET), which uses positron-emitting radionuclides and detects the coincident gamma rays emitted by the annihilation of positrons and electrons.

Overall, ECT is a valuable tool in medical imaging for diagnosing and monitoring various diseases, including cancer, heart disease, and neurological disorders.

Fluorine radioisotopes are radioactive isotopes or variants of the chemical element Fluorine (F, atomic number 9). These radioisotopes have an unstable nucleus that emits radiation in the form of alpha particles, beta particles, or gamma rays. Examples of Fluorine radioisotopes include Fluorine-18 and Fluorine-19.

Fluorine-18 is a positron-emitting radionuclide with a half-life of approximately 110 minutes, making it useful for medical imaging techniques such as Positron Emission Tomography (PET) scans. It is commonly used in the production of fluorodeoxyglucose (FDG), a radiopharmaceutical that can be used to detect cancer and other metabolic disorders.

Fluorine-19, on the other hand, is a stable isotope of Fluorine and does not emit radiation. However, it can be enriched and used as a non-radioactive tracer in medical research and diagnostic applications.

Sodium iodide is a chemical compound with the formula NaI. It is a white, crystalline solid that is widely used in medicine, particularly as a radiocontrast agent for imaging procedures such as CT scans and X-rays. Sodium iodide is also used in the treatment of thyroid disorders because it contains iodine, which is an essential nutrient for proper thyroid function.

In medical applications, sodium iodide may be combined with a radioactive isotope such as technetium-99m or iodine-131 to create a radiopharmaceutical that can be used to diagnose or treat various conditions. The radiation emitted by the isotope can be detected by medical imaging equipment, allowing doctors to visualize and assess the function of organs and tissues within the body.

It's important to note that sodium iodide should only be used under the supervision of a qualified healthcare professional, as it may have potential side effects and risks associated with its use.

I'm sorry for any confusion, but "Ytterbium" is not a medical term. It is a chemical element with the symbol "Yb" and atomic number 70. Ytterbium is a rare earth metal that is silvery white, soft, malleable, and has many uses in scientific research, particularly in the field of laser technology.

If you have any medical questions or terms you would like me to define, please let me know!

Radiologic technology is a medical term that refers to the use of imaging technologies to diagnose and treat diseases. It involves the application of various forms of radiation, such as X-rays, magnetic fields, sound waves, and radioactive substances, to create detailed images of the internal structures of the body.

Radiologic technologists are healthcare professionals who operate the imaging equipment and work closely with radiologists, who are medical doctors specializing in interpreting medical images. Radiologic technology includes various imaging modalities such as:

1. X-ray radiography: produces images of internal structures by passing X-rays through the body onto a detector.
2. Computed tomography (CT): uses X-rays to create detailed cross-sectional images of the body.
3. Magnetic resonance imaging (MRI): uses magnetic fields and radio waves to produce detailed images of internal structures without using radiation.
4. Ultrasound: uses high-frequency sound waves to create images of internal structures, such as fetuses during pregnancy or organs like the heart and liver.
5. Nuclear medicine: uses small amounts of radioactive substances to diagnose and treat diseases by creating detailed images of the body's internal structures and functions.

Radiologic technology plays a crucial role in modern medicine, enabling healthcare providers to make accurate diagnoses, plan treatments, and monitor patient progress.

I'm sorry for any confusion, but "Oxyquinoline" does not have a specific medical definition as it is not a widely recognized medical term or a medication used in human healthcare. Oxyquinoline is an organic compound that contains a quinoline ring substituted with an alcohol group (hydroxyl) at position 8. It has been used in the past as a disinfectant and antiseptic, but it's not common in modern medical practice.

If you have any questions about medical terminology or concepts, please provide more context so I can offer a more accurate and helpful response.

Gallium is not a medical term, but it's a chemical element with the symbol Ga and atomic number 31. It is a soft, silvery-blue metal that melts at a temperature just above room temperature. In medicine, gallium compounds such as gallium nitrate and gallium citrate are used as radiopharmaceuticals for diagnostic purposes in nuclear medicine imaging studies, particularly in the detection of inflammation, infection, and some types of cancer.

For example, Gallium-67 is a radioactive isotope that can be injected into the body to produce images of various diseases such as abscesses, osteomyelitis (bone infection), and tumors using a gamma camera. The way gallium distributes in the body can provide valuable information about the presence and extent of disease.

Therefore, while gallium is not a medical term itself, it has important medical applications as a diagnostic tool in nuclear medicine.

Technetium Tc 99m Aggregated Albumin is a radiopharmaceutical preparation used in diagnostic imaging. It consists of radioactive technetium-99m (^99m^Tc) chemically bonded to human serum albumin, which has been aggregated to increase its size and alter its clearance from the body.

The resulting compound is injected into the patient's bloodstream, where it accumulates in the reticuloendothelial system (RES), including the liver, spleen, and bone marrow. The radioactive emission of technetium-99m can then be detected by a gamma camera, producing images that reflect the distribution and function of the RES.

This imaging technique is used to diagnose and monitor various conditions, such as liver disease, inflammation, or tumors. It provides valuable information about the patient's health status and helps guide medical decision-making.

Cobalt radioisotopes are radioactive forms of the element cobalt, which are used in various medical applications. The most commonly used cobalt radioisotope is Cobalt-60 (Co-60), which has a half-life of 5.27 years.

Co-60 emits gamma rays and beta particles, making it useful for radiation therapy to treat cancer, as well as for sterilizing medical equipment and food irradiation. In radiation therapy, Co-60 is used in teletherapy machines to deliver a focused beam of radiation to tumors, helping to destroy cancer cells while minimizing damage to surrounding healthy tissue.

It's important to note that handling and disposal of cobalt radioisotopes require strict safety measures due to their radioactive nature, as they can pose risks to human health and the environment if not managed properly.

Imino acids are organic compounds that contain a nitrogen atom as part of an amide-like structure. They are structurally similar to amino acids, which contain a carboxyl group and an amino group, but instead of the amino group, imino acids have a structural unit known as an imine or Schiff base, which is a carbon-nitrogen double bond with a hydrogen atom attached to the nitrogen atom.

One example of an imino acid is proline, which is a cyclic imino acid that plays important roles in protein structure and function. Proline is unique among the 20 standard amino acids because its side chain is linked to the nitrogen atom of the backbone, forming a ring-like structure. This structural feature gives proline unique properties, such as restricted rotation around the bond between the nitrogen and alpha carbon atoms, which can affect protein folding and stability.

Other imino acids may be formed through chemical reactions or enzymatic processes, and they can play important roles in various biological pathways, including the biosynthesis of amino acids, nucleotides, and other biomolecules. However, imino acids are not typically considered to be part of the standard set of 20 amino acids that make up proteins.

A Nuclear Medicine Department in a hospital is a specialized unit that uses small amounts of radioactive materials, called radiopharmaceuticals, to diagnose and treat various medical conditions. These radiopharmaceuticals are introduced into the body through different routes (such as injection, inhalation, or ingestion) and accumulate in specific organs or cells, where they emit gamma rays that can be detected by external imaging devices.

The Nuclear Medicine Department performs various diagnostic procedures, including:

1. Imaging studies: These tests produce images of the body's internal structures and functions to help diagnose and monitor diseases. Examples include bone scans, lung scans, heart scans (such as myocardial perfusion imaging), brain scans, and kidney scans.
2. Therapeutic procedures: Nuclear medicine also offers treatments for certain medical conditions using radioactive materials. For example, radioiodine therapy is used to treat thyroid cancer and hyperthyroidism.

The department typically consists of a team of healthcare professionals, including nuclear medicine physicians, radiologists, technologists, nurses, and support staff, who work together to provide high-quality care for patients undergoing nuclear medicine procedures.

Fluorodeoxyglucose F18 (FDG-18) is not a medical condition, but a radiopharmaceutical used in medical imaging. It is a type of glucose (a simple sugar) that has been chemically combined with a small amount of a radioactive isotope called fluorine-18.

FDG-18 is used in positron emission tomography (PET) scans to help identify areas of the body where cells are using more energy than normal, such as cancerous tumors. The FDG-18 is injected into the patient's vein and travels throughout the body. Because cancer cells often use more glucose than normal cells, they tend to absorb more FDG-18.

Once inside the body, the FDG-18 emits positrons, which interact with electrons in nearby tissue, producing gamma rays that can be detected by a PET scanner. The resulting images can help doctors locate and assess the size and activity of cancerous tumors, as well as monitor the effectiveness of treatment.

Technetium Tc 99m Dimercaptosuccinic Acid (DMSA) is a radiopharmaceutical agent used in nuclear medicine imaging procedures. The compound is made up of the radioisotope Technetium-99m, which emits gamma rays that can be detected by a gamma camera, and dimercaptosuccinic acid, which binds to certain types of metal ions in the body.

In medical imaging, Technetium Tc 99m DMSA is typically used to visualize the kidneys and detect any abnormalities such as inflammation, infection, or tumors. The compound is taken up by the renal tubules in the kidneys, allowing for detailed images of the kidney structure and function to be obtained.

It's important to note that the use of Technetium Tc 99m DMSA should be under the supervision of a trained medical professional, as with any radiopharmaceutical agent, due to the radiation exposure involved in its use.

Coordination complexes are chemical compounds in which a central metal atom or ion is bonded to one or more ligands (molecules or ions that donate a pair of electrons to form a coordinate covalent bond) through a coordination number, which refers to the number of individual bonds formed between the metal and the ligands.

The structure and properties of coordination complexes are determined by the type of metal ion, the nature and number of ligands, and the geometry of the coordination sphere around the metal ion. These complexes have important applications in various fields such as catalysis, bioinorganic chemistry, materials science, and medicinal chemistry.

The formation of coordination complexes can be described by the following reaction:

M + nL ↔ MLn

Where M is the metal ion, L is the ligand, and n is the number of ligands bonded to the metal ion. The double arrow indicates that the reaction can proceed in both directions, with the equilibrium favoring either the formation or dissociation of the complex depending on various factors such as temperature, pressure, and concentration.

The study of coordination complexes is an important area of inorganic chemistry, and it involves understanding the electronic structure, bonding, and reactivity of these compounds. The use of crystal field theory and molecular orbital theory provides a framework for describing the behavior of coordination complexes and predicting their properties.

Diphosphates, also known as pyrophosphates, are chemical compounds that contain two phosphate groups joined together by an oxygen atom. The general formula for a diphosphate is P~PO3~2-, where ~ represents a bond. Diphosphates play important roles in various biological processes, such as energy metabolism and cell signaling. In the context of nutrition, diphosphates can be found in some foods, including milk and certain vegetables.

Technetium Tc 99m Mertiatide is a radiopharmaceutical used in nuclear medicine imaging procedures. It is a technetium-labeled compound, where the radioisotope technetium-99m (^99m^Tc) is bound to mercaptoacetyltriglycine (MAG3). The resulting complex is known as ^99m^Tc-MAG3 or Technetium Tc 99m Mertiatide.

This radiopharmaceutical is primarily used for renal function assessment, including evaluation of kidney blood flow, glomerular filtration rate (GFR), and detection of renal obstructions or other abnormalities. After intravenous administration, Technetium Tc 99m Mertiatide is rapidly excreted by the kidneys, allowing for visualization and quantification of renal function through gamma camera imaging.

It's important to note that the use of radiopharmaceuticals should be performed under the guidance of a qualified healthcare professional, as they involve the administration of radioactive materials for diagnostic purposes.

3-Iodobenzylguanidine (3-IBG) is a radioactive tracer drug that is used in nuclear medicine to help diagnose and evaluate pheochromocytomas and paragangliomas, which are rare tumors of the adrenal glands or nearby nerve tissue. It works by accumulating in the cells of these tumors, allowing them to be detected through imaging techniques such as single-photon emission computed tomography (SPECT) scans.

The drug contains a radioactive isotope of iodine (I-123 or I-131) that emits gamma rays, which can be detected by a gamma camera during the imaging procedure. The 3-IBG molecule also includes a guanidine group, which selectively binds to the norepinephrine transporter (NET) on the surface of the tumor cells, allowing the drug to accumulate within the tumor tissue.

It is important to note that the use of 3-IBG should be under the supervision of a qualified healthcare professional, as it involves exposure to radiation and may have potential side effects.

Technetium Tc 99m Sulfur Colloid is a radioactive tracer used in medical imaging procedures, specifically in nuclear medicine. It is composed of tiny particles of sulfur colloid that are labeled with the radioisotope Technetium-99m. This compound is typically injected into the patient's body, where it accumulates in certain organs or tissues, depending on the specific medical test being conducted.

The radioactive emissions from Technetium Tc 99m Sulfur Colloid are then detected by a gamma camera, which produces images that can help doctors diagnose various medical conditions, such as liver disease, inflammation, or tumors. The half-life of Technetium-99m is approximately six hours, which means that its radioactivity decreases rapidly and is eliminated from the body within a few days.

Radiation monitoring is the systematic and continuous measurement, assessment, and tracking of ionizing radiation levels in the environment or within the body to ensure safety and to take appropriate actions when limits are exceeded. It involves the use of specialized instruments and techniques to detect and quantify different types of radiation, such as alpha, beta, gamma, neutron, and x-rays. The data collected from radiation monitoring is used to evaluate radiation exposure, contamination levels, and potential health risks for individuals or communities. This process is crucial in various fields, including nuclear energy production, medical imaging and treatment, radiation therapy, and environmental protection.

Somatostatin receptors (SSTRs) are a group of G protein-coupled receptors that bind to the neuropeptide hormone somatostatin. There are five subtypes of SSTRs, named SSTR1 through SSTR5, each with distinct physiological roles and tissue distributions.

Somatostatin is a small peptide that is widely distributed throughout the body, including in the central nervous system, gastrointestinal tract, pancreas, and other endocrine organs. It has multiple functions, including inhibition of hormone release, regulation of cell proliferation, and modulation of neurotransmission.

SSTRs are expressed on the surface of many different types of cells, including neurons, endocrine cells, and immune cells. They play important roles in regulating various physiological processes, such as inhibiting the release of hormones like insulin, glucagon, and growth hormone. SSTRs have also been implicated in a number of pathophysiological conditions, including cancer, neurodegenerative diseases, and inflammatory disorders.

In recent years, SSTRs have become an important target for the development of new therapeutic strategies, particularly in the treatment of neuroendocrine tumors (NETs). Several radiolabeled somatostatin analogues have been developed that can selectively bind to SSTRs on NET cells and deliver targeted radiation therapy. These agents have shown promising results in clinical trials and are now being used as standard of care for patients with advanced NETs.

Alpha-Methyltyrosine (α-MT) is a synthetic amino acid that acts as an inhibitor of the enzyme tyrosine hydroxylase. This enzyme is a rate-limiting step in the biosynthesis of catecholamines, including neurotransmitters such as dopamine and norepinephrine. By inhibiting tyrosine hydroxylase, α-MT reduces the synthesis of these catecholamines, which can lead to various effects on the nervous system.

In medical contexts, α-MT has been used in research settings to study the functions of catecholamines and their role in various physiological processes. It has also been investigated as a potential treatment for certain conditions, such as hypertension and anxiety disorders, although its clinical use is not widespread due to its side effects and limited efficacy.

It's important to note that α-MT should only be used under the supervision of a medical professional, as it can have significant effects on the nervous system and may interact with other medications or health conditions.

Neuroendocrine tumors (NETs) are a diverse group of neoplasms that arise from cells of the neuroendocrine system, which is composed of dispersed neuroendocrine cells throughout the body, often in close association with nerves and blood vessels. These cells have the ability to produce and secrete hormones or hormone-like substances in response to various stimuli. NETs can occur in a variety of organs, including the lungs, pancreas, small intestine, colon, rectum, stomach, and thyroid gland, as well as in some less common sites such as the thymus, adrenal glands, and nervous system.

NETs can be functional or nonfunctional, depending on whether they produce and secrete hormones or hormone-like substances that cause specific symptoms related to hormonal excess. Functional NETs may give rise to a variety of clinical syndromes, such as carcinoid syndrome, Zollinger-Ellison syndrome, pancreatic neuroendocrine tumor syndrome (also known as Verner-Morrison or WDHA syndrome), and others. Nonfunctional NETs are more likely to present with symptoms related to the size and location of the tumor, such as abdominal pain, intestinal obstruction, or bleeding.

The diagnosis of NETs typically involves a combination of imaging studies, biochemical tests (e.g., measurement of serum hormone levels), and histopathological examination of tissue samples obtained through biopsy or surgical resection. Treatment options depend on the type, location, stage, and grade of the tumor, as well as the presence or absence of functional symptoms. They may include surgery, radiation therapy, chemotherapy, targeted therapy, and/or peptide receptor radionuclide therapy (PRRT).

Metabolic clearance rate is a term used in pharmacology to describe the volume of blood or plasma from which a drug is completely removed per unit time by metabolic processes. It is a measure of the body's ability to eliminate a particular substance and is usually expressed in units of volume (e.g., milliliters or liters) per time (e.g., minutes, hours, or days).

The metabolic clearance rate can be calculated by dividing the total amount of drug eliminated by the plasma concentration of the drug and the time over which it was eliminated. It provides important information about the pharmacokinetics of a drug, including its rate of elimination and the potential for drug-drug interactions that may affect metabolism.

It is worth noting that there are different types of clearance rates, such as renal clearance rate (which refers to the removal of a drug by the kidneys) or hepatic clearance rate (which refers to the removal of a drug by the liver). Metabolic clearance rate specifically refers to the elimination of a drug through metabolic processes, which can occur in various organs throughout the body.

Technetium Tc 99m Sestamibi is a radiopharmaceutical compound used in medical imaging, specifically in myocardial perfusion scintigraphy. It is a technetium-labeled isonitrile chelate that is taken up by mitochondria in cells with high metabolic activity, such as cardiomyocytes (heart muscle cells).

Once injected into the patient's body, Technetium Tc 99m Sestamibi emits gamma rays, which can be detected by a gamma camera. This allows for the creation of images that reflect the distribution and function of the radiopharmaceutical within the heart muscle. The images can help identify areas of reduced blood flow or ischemia, which may indicate coronary artery disease.

The uptake of Technetium Tc 99m Sestamibi in other organs, such as the breast and thyroid, can also be used for imaging purposes, although its primary use remains in cardiac imaging.

Organophosphorus compounds are a class of chemical substances that contain phosphorus bonded to organic compounds. They are used in various applications, including as plasticizers, flame retardants, pesticides (insecticides, herbicides, and nerve gases), and solvents. In medicine, they are also used in the treatment of certain conditions such as glaucoma. However, organophosphorus compounds can be toxic to humans and animals, particularly those that affect the nervous system by inhibiting acetylcholinesterase, an enzyme that breaks down the neurotransmitter acetylcholine. Exposure to these compounds can cause symptoms such as nausea, vomiting, muscle weakness, and in severe cases, respiratory failure and death.

Chelating agents are substances that can bind and form stable complexes with certain metal ions, preventing them from participating in chemical reactions. In medicine, chelating agents are used to remove toxic or excessive amounts of metal ions from the body. For example, ethylenediaminetetraacetic acid (EDTA) is a commonly used chelating agent that can bind with heavy metals such as lead and mercury, helping to eliminate them from the body and reduce their toxic effects. Other chelating agents include dimercaprol (BAL), penicillamine, and deferoxamine. These agents are used to treat metal poisoning, including lead poisoning, iron overload, and copper toxicity.

Octreotide is a synthetic analogue of the natural hormone somatostatin, which is used in medical treatment. It is a octapeptide with similar effects to somatostatin, but with a longer duration of action. Octreotide is primarily used in the management of acromegaly, gastroenteropancreatic neuroendocrine tumors (GEP-NETs), and diarrhea and flushing associated with carcinoid syndrome.

It works by inhibiting the release of several hormones, including growth hormone, insulin, glucagon, and gastrin. This results in a decrease in symptoms caused by excessive hormone secretion, such as reduced growth hormone levels in acromegaly, decreased tumor size in some GEP-NETs, and improved diarrhea and flushing in carcinoid syndrome.

Octreotide is available in several forms, including short-acting subcutaneous injections (Sandostatin®), long-acting depot intramuscular injections (Sandostatin LAR®), and a slow-release formulation for the treatment of diarrhea associated with AIDS (Mycapssa™).

The medical definition of Octreotide is:

A synthetic octapeptide analogue of somatostatin, used in the management of acromegaly, gastroenteropancreatic neuroendocrine tumors (GEP-NETs), and diarrhea and flushing associated with carcinoid syndrome. Octreotide inhibits the release of several hormones, including growth hormone, insulin, glucagon, and gastrin, leading to symptomatic improvement in these conditions. It is available as short-acting subcutaneous injections, long-acting depot intramuscular injections, and a slow-release formulation for diarrhea associated with AIDS.

Radioimmunotherapy (RIT) is a medical treatment that combines the specificity of antibodies and the therapeutic effects of radiation to target and destroy cancer cells. It involves the use of radioactive isotopes, which are attached to monoclonal antibodies, that recognize and bind to antigens expressed on the surface of cancer cells. Once bound, the radioactivity emitted from the isotope irradiates the cancer cells, causing damage to their DNA and leading to cell death. This targeted approach helps minimize radiation exposure to healthy tissues and reduces side effects compared to conventional radiotherapy techniques. RIT has been used in the treatment of various hematological malignancies, such as non-Hodgkin lymphoma, and is being investigated for solid tumors as well.

Iofetamine is a radiopharmaceutical agent used in myocardial perfusion imaging, a type of nuclear stress test. It is a derivative of the amphetamine family and functions as a vasoconstrictor when administered. Iofetamine is labeled with technetium-99m (^99mTc) before use, which allows for the detection and imaging of the heart's blood flow and function during rest and stress conditions. This information helps physicians diagnose and assess coronary artery disease and evaluate the effectiveness of treatments.

The medical definition of Iofetamine is:

A radiopharmaceutical agent, (^99mTc)Tc-sestamibi or (^99mTc)Tc-MIBI, used in myocardial perfusion imaging for the assessment of coronary artery disease. Iofetamine is a lipophilic cation that accumulates in myocardial cells in proportion to regional blood flow. The technetium-99m label enables gamma camera detection and imaging, providing information about the heart's blood flow and function during rest and stress conditions.

Radioimmunodetection (RID) is a medical diagnostic technique that combines the specificity of antibodies with the sensitivity of radioisotopes to detect and locate antigens or tumor markers within the body. This technique involves labeling antibodies with radioactive isotopes, which are then introduced into the patient's body. The labeled antibodies bind to the target antigens, allowing for their detection and localization using external gamma cameras.

The process typically begins with the production of monoclonal or polyclonal antibodies that specifically recognize and bind to a particular antigen associated with a disease or condition. These antibodies are then labeled with radioisotopes such as technetium-99m, iodine-131, or indium-111, which emit gamma rays that can be detected by external imaging devices.

Once the labeled antibodies have been administered to the patient, they circulate throughout the body and bind to their respective antigens. The bound radioactive antibodies can then be imaged using a gamma camera or single-photon emission computed tomography (SPECT) scanner, providing information about the location, size, and distribution of the target antigens within the body.

Radioimmunodetection has been widely used in the detection and monitoring of various malignancies, including cancerous tumors and metastases, as well as inflammatory and infectious diseases. It offers several advantages over other diagnostic techniques, such as high sensitivity, specificity, and non-invasiveness, making it an essential tool in modern medical imaging and diagnostics.

Technetium Tc 99m Exametazime is a radiopharmaceutical agent used in nuclear medicine imaging procedures. The compound consists of the radioisotope Technetium-99m (^99m^Tc) bonded to Exametazime, also known as HMPAO (hexamethylpropyleneamine oxime).

Once injected into the patient's bloodstream, Technetium Tc 99m Exametazime distributes evenly throughout the brain, crossing the blood-brain barrier and entering cells. The radioactive decay of Technetium-99m emits gamma rays that can be detected by a gamma camera, creating images of the brain's blood flow and distribution of the tracer.

This imaging technique is often used in cerebral perfusion studies to assess conditions such as stroke, epilepsy, or dementia, providing valuable information about regional cerebral blood flow and potential areas of injury or abnormality.

Bone neoplasms are abnormal growths or tumors that develop in the bone. They can be benign (non-cancerous) or malignant (cancerous). Benign bone neoplasms do not spread to other parts of the body and are rarely a threat to life, although they may cause problems if they grow large enough to press on surrounding tissues or cause fractures. Malignant bone neoplasms, on the other hand, can invade and destroy nearby tissue and may spread (metastasize) to other parts of the body.

There are many different types of bone neoplasms, including:

1. Osteochondroma - a benign tumor that develops from cartilage and bone
2. Enchondroma - a benign tumor that forms in the cartilage that lines the inside of the bones
3. Chondrosarcoma - a malignant tumor that develops from cartilage
4. Osteosarcoma - a malignant tumor that develops from bone cells
5. Ewing sarcoma - a malignant tumor that develops in the bones or soft tissues around the bones
6. Giant cell tumor of bone - a benign or occasionally malignant tumor that develops from bone tissue
7. Fibrosarcoma - a malignant tumor that develops from fibrous tissue in the bone

The symptoms of bone neoplasms vary depending on the type, size, and location of the tumor. They may include pain, swelling, stiffness, fractures, or limited mobility. Treatment options depend on the type and stage of the tumor but may include surgery, radiation therapy, chemotherapy, or a combination of these treatments.

Oximes are a class of chemical compounds that contain the functional group =N-O-, where two organic groups are attached to the nitrogen atom. In a clinical context, oximes are used as antidotes for nerve agent and pesticide poisoning. The most commonly used oxime in medicine is pralidoxime (2-PAM), which is used to reactivate acetylcholinesterase that has been inhibited by organophosphorus compounds, such as nerve agents and certain pesticides. These compounds work by forming a bond with the phosphoryl group of the inhibited enzyme, allowing for its reactivation and restoration of normal neuromuscular function.

Citrates are the salts or esters of citric acid, a weak organic acid that is naturally found in many fruits and vegetables. In a medical context, citrates are often used as a buffering agent in intravenous fluids to help maintain the pH balance of blood and other bodily fluids. They are also used in various medical tests and treatments, such as in urine alkalinization and as an anticoagulant in kidney dialysis solutions. Additionally, citrate is a component of some dietary supplements and medications.

Tomography is a medical imaging technique used to produce cross-sectional images or slices of specific areas of the body. This technique uses various forms of radiation (X-rays, gamma rays) or sound waves (ultrasound) to create detailed images of the internal structures, such as organs, bones, and tissues. Common types of tomography include Computerized Tomography (CT), Positron Emission Tomography (PET), and Magnetic Resonance Imaging (MRI). The primary advantage of tomography is its ability to provide clear and detailed images of internal structures, allowing healthcare professionals to accurately diagnose and monitor a wide range of medical conditions.

Diagnostic imaging is a medical specialty that uses various technologies to produce visual representations of the internal structures and functioning of the body. These images are used to diagnose injury, disease, or other abnormalities and to monitor the effectiveness of treatment. Common modalities of diagnostic imaging include:

1. Radiography (X-ray): Uses ionizing radiation to produce detailed images of bones, teeth, and some organs.
2. Computed Tomography (CT) Scan: Combines X-ray technology with computer processing to create cross-sectional images of the body.
3. Magnetic Resonance Imaging (MRI): Uses a strong magnetic field and radio waves to generate detailed images of soft tissues, organs, and bones.
4. Ultrasound: Employs high-frequency sound waves to produce real-time images of internal structures, often used for obstetrics and gynecology.
5. Nuclear Medicine: Involves the administration of radioactive tracers to assess organ function or detect abnormalities within the body.
6. Positron Emission Tomography (PET) Scan: Uses a small amount of radioactive material to produce detailed images of metabolic activity in the body, often used for cancer detection and monitoring treatment response.
7. Fluoroscopy: Utilizes continuous X-ray imaging to observe moving structures or processes within the body, such as swallowing studies or angiography.

Diagnostic imaging plays a crucial role in modern medicine, allowing healthcare providers to make informed decisions about patient care and treatment plans.

Colloids are a type of mixture that contains particles that are intermediate in size between those found in solutions and suspensions. These particles range in size from about 1 to 1000 nanometers in diameter, which is smaller than what can be seen with the naked eye, but larger than the molecules in a solution.

Colloids are created when one substance, called the dispersed phase, is dispersed in another substance, called the continuous phase. The dispersed phase can consist of particles such as proteins, emulsified fats, or finely divided solids, while the continuous phase is usually a liquid, but can also be a gas or a solid.

Colloids are important in many areas of medicine and biology, including drug delivery, diagnostic imaging, and tissue engineering. They are also found in nature, such as in milk, blood, and fog. The properties of colloids can be affected by factors such as pH, temperature, and the presence of other substances, which can influence their stability and behavior.

Neoplasms are abnormal growths of cells or tissues in the body that serve no physiological function. They can be benign (non-cancerous) or malignant (cancerous). Benign neoplasms are typically slow growing and do not spread to other parts of the body, while malignant neoplasms are aggressive, invasive, and can metastasize to distant sites.

Neoplasms occur when there is a dysregulation in the normal process of cell division and differentiation, leading to uncontrolled growth and accumulation of cells. This can result from genetic mutations or other factors such as viral infections, environmental exposures, or hormonal imbalances.

Neoplasms can develop in any organ or tissue of the body and can cause various symptoms depending on their size, location, and type. Treatment options for neoplasms include surgery, radiation therapy, chemotherapy, immunotherapy, and targeted therapy, among others.

Technetium Tc 99m Pentetate is a radioactive pharmaceutical preparation used as a radiopharmaceutical agent in medical imaging. It is a salt of technetium-99m, a metastable nuclear isomer of technetium-99, which emits gamma rays and has a half-life of 6 hours.

Technetium Tc 99m Pentetate is used in various diagnostic procedures, including renal imaging, brain scans, lung perfusion studies, and bone scans. It is distributed throughout the body after intravenous injection and is excreted primarily by the kidneys, making it useful for evaluating renal function and detecting abnormalities in the urinary tract.

The compound itself is a colorless, sterile, pyrogen-free solution that is typically supplied in a lead shielded container to protect against radiation exposure. It should be used promptly after preparation and handled with care to minimize radiation exposure to healthcare workers and patients.

Carbon radioisotopes are radioactive isotopes of carbon, which is an naturally occurring chemical element with the atomic number 6. The most common and stable isotope of carbon is carbon-12 (^12C), but there are also several radioactive isotopes, including carbon-11 (^11C), carbon-14 (^14C), and carbon-13 (^13C). These radioisotopes have different numbers of neutrons in their nuclei, which makes them unstable and causes them to emit radiation.

Carbon-11 has a half-life of about 20 minutes and is used in medical imaging techniques such as positron emission tomography (PET) scans. It is produced by bombarding nitrogen-14 with protons in a cyclotron.

Carbon-14, also known as radiocarbon, has a half-life of about 5730 years and is used in archaeology and geology to date organic materials. It is produced naturally in the atmosphere by cosmic rays.

Carbon-13 is stable and has a natural abundance of about 1.1% in carbon. It is not radioactive, but it can be used as a tracer in medical research and in the study of metabolic processes.

In the field of medical imaging, "phantoms" refer to physical objects that are specially designed and used for calibration, quality control, and evaluation of imaging systems. These phantoms contain materials with known properties, such as attenuation coefficients or spatial resolution, which allow for standardized measurement and comparison of imaging parameters across different machines and settings.

Imaging phantoms can take various forms depending on the modality of imaging. For example, in computed tomography (CT), a common type of phantom is the "water-equivalent phantom," which contains materials with similar X-ray attenuation properties as water. This allows for consistent measurement of CT dose and image quality. In magnetic resonance imaging (MRI), phantoms may contain materials with specific relaxation times or magnetic susceptibilities, enabling assessment of signal-to-noise ratio, spatial resolution, and other imaging parameters.

By using these standardized objects, healthcare professionals can ensure the accuracy, consistency, and reliability of medical images, ultimately contributing to improved patient care and safety.

Radiotherapy dosage refers to the total amount of radiation energy that is absorbed by tissues or organs, typically measured in units of Gray (Gy), during a course of radiotherapy treatment. It is the product of the dose rate (the amount of radiation delivered per unit time) and the duration of treatment. The prescribed dosage for cancer treatments can range from a few Gray to more than 70 Gy, depending on the type and location of the tumor, the patient's overall health, and other factors. The goal of radiotherapy is to deliver a sufficient dosage to destroy the cancer cells while minimizing damage to surrounding healthy tissues.

Molecular imaging is a type of medical imaging that provides detailed pictures of what is happening at the molecular and cellular level in the body. It involves the use of specialized imaging devices and radiopharmaceuticals (radiotracers) to visualize and measure biological processes, such as gene expression, protein expression, or metabolic activity, within cells and tissues. This information can be used to detect disease at its earliest stages, monitor response to therapy, and guide the development of new treatments.

Molecular imaging techniques include positron emission tomography (PET), single-photon emission computed tomography (SPECT), magnetic resonance imaging (MRI), and computed tomography (CT). These techniques differ in their ability to provide functional, anatomical, or molecular information about the body.

Overall, molecular imaging is a powerful tool for non-invasively visualizing and understanding biological processes at the molecular level, which can lead to improved diagnosis, treatment planning, and patient outcomes.

Iodobenzenes are organic compounds that contain a iodine atom (I) attached to a benzene ring. The general formula for iodobenzenes is C6H5I. They can be considered as aryl halides and can undergo various chemical reactions such as nucleophilic substitution, electrophilic aromatic substitution, and reduction. Iodobenzenes are less reactive than other aryl halides due to the larger size and lower electronegativity of iodine compared to other halogens. They are used in organic synthesis as building blocks or reagents for various chemical transformations.

"Quality control" is a term that is used in many industries, including healthcare and medicine, to describe the systematic process of ensuring that products or services meet certain standards and regulations. In the context of healthcare, quality control often refers to the measures taken to ensure that the care provided to patients is safe, effective, and consistent. This can include processes such as:

1. Implementing standardized protocols and guidelines for care
2. Training and educating staff to follow these protocols
3. Regularly monitoring and evaluating the outcomes of care
4. Making improvements to processes and systems based on data and feedback
5. Ensuring that equipment and supplies are maintained and functioning properly
6. Implementing systems for reporting and addressing safety concerns or errors.

The goal of quality control in healthcare is to provide high-quality, patient-centered care that meets the needs and expectations of patients, while also protecting their safety and well-being.

Autoradiography is a medical imaging technique used to visualize and localize the distribution of radioactively labeled compounds within tissues or organisms. In this process, the subject is first exposed to a radioactive tracer that binds to specific molecules or structures of interest. The tissue is then placed in close contact with a radiation-sensitive film or detector, such as X-ray film or an imaging plate.

As the radioactive atoms decay, they emit particles (such as beta particles) that interact with the film or detector, causing chemical changes and leaving behind a visible image of the distribution of the labeled compound. The resulting autoradiogram provides information about the location, quantity, and sometimes even the identity of the molecules or structures that have taken up the radioactive tracer.

Autoradiography has been widely used in various fields of biology and medical research, including pharmacology, neuroscience, genetics, and cell biology, to study processes such as protein-DNA interactions, gene expression, drug metabolism, and neuronal connectivity. However, due to the use of radioactive materials and potential hazards associated with them, this technique has been gradually replaced by non-radioactive alternatives like fluorescence in situ hybridization (FISH) or immunofluorescence techniques.

Drug delivery systems (DDS) refer to techniques or technologies that are designed to improve the administration of a pharmaceutical compound in terms of its efficiency, safety, and efficacy. A DDS can modify the drug release profile, target the drug to specific cells or tissues, protect the drug from degradation, and reduce side effects.

The goal of a DDS is to optimize the bioavailability of a drug, which is the amount of the drug that reaches the systemic circulation and is available at the site of action. This can be achieved through various approaches, such as encapsulating the drug in a nanoparticle or attaching it to a biomolecule that targets specific cells or tissues.

Some examples of DDS include:

1. Controlled release systems: These systems are designed to release the drug at a controlled rate over an extended period, reducing the frequency of dosing and improving patient compliance.
2. Targeted delivery systems: These systems use biomolecules such as antibodies or ligands to target the drug to specific cells or tissues, increasing its efficacy and reducing side effects.
3. Nanoparticle-based delivery systems: These systems use nanoparticles made of polymers, lipids, or inorganic materials to encapsulate the drug and protect it from degradation, improve its solubility, and target it to specific cells or tissues.
4. Biodegradable implants: These are small devices that can be implanted under the skin or into body cavities to deliver drugs over an extended period. They can be made of biodegradable materials that gradually break down and release the drug.
5. Inhalation delivery systems: These systems use inhalers or nebulizers to deliver drugs directly to the lungs, bypassing the digestive system and improving bioavailability.

Overall, DDS play a critical role in modern pharmaceutical research and development, enabling the creation of new drugs with improved efficacy, safety, and patient compliance.

In medical terms, the heart is a muscular organ located in the thoracic cavity that functions as a pump to circulate blood throughout the body. It's responsible for delivering oxygen and nutrients to the tissues and removing carbon dioxide and other wastes. The human heart is divided into four chambers: two atria on the top and two ventricles on the bottom. The right side of the heart receives deoxygenated blood from the body and pumps it to the lungs, while the left side receives oxygenated blood from the lungs and pumps it out to the rest of the body. The heart's rhythmic contractions and relaxations are regulated by a complex electrical conduction system.

I believe there might be a misunderstanding in your question. "Dogs" is not a medical term or condition. It is the common name for a domesticated carnivore of the family Canidae, specifically the genus Canis, which includes wolves, foxes, and other extant and extinct species of mammals. Dogs are often kept as pets and companions, and they have been bred in a wide variety of forms and sizes for different purposes, such as hunting, herding, guarding, assisting police and military forces, and providing companionship and emotional support.

If you meant to ask about a specific medical condition or term related to dogs, please provide more context so I can give you an accurate answer.

A dose-response relationship in radiation refers to the correlation between the amount of radiation exposure (dose) and the biological response or adverse health effects observed in exposed individuals. As the level of radiation dose increases, the severity and frequency of the adverse health effects also tend to increase. This relationship is crucial in understanding the risks associated with various levels of radiation exposure and helps inform radiation protection standards and guidelines.

The effects of ionizing radiation can be categorized into two types: deterministic and stochastic. Deterministic effects have a threshold dose below which no effect is observed, and above this threshold, the severity of the effect increases with higher doses. Examples include radiation-induced cataracts or radiation dermatitis. Stochastic effects, on the other hand, do not have a clear threshold and are based on probability; as the dose increases, so does the likelihood of the adverse health effect occurring, such as an increased risk of cancer.

Understanding the dose-response relationship in radiation exposure is essential for setting limits on occupational and public exposure to ionizing radiation, optimizing radiation protection practices, and developing effective medical countermeasures in case of radiation emergencies.

Diphosphonates are a class of medications that are used to treat bone diseases, such as osteoporosis and Paget's disease. They work by binding to the surface of bones and inhibiting the activity of bone-resorbing cells called osteoclasts. This helps to slow down the breakdown and loss of bone tissue, which can help to reduce the risk of fractures.

Diphosphonates are typically taken orally in the form of tablets, but some forms may be given by injection. Commonly prescribed diphosphonates include alendronate (Fosamax), risedronate (Actonel), and ibandronate (Boniva). Side effects of diphosphonates can include gastrointestinal symptoms such as nausea, heartburn, and abdominal pain. In rare cases, they may also cause esophageal ulcers or osteonecrosis of the jaw.

It is important to follow the instructions for taking diphosphonates carefully, as they must be taken on an empty stomach with a full glass of water and the patient must remain upright for at least 30 minutes after taking the medication to reduce the risk of esophageal irritation. Regular monitoring of bone density and kidney function is also recommended while taking these medications.

Neoplasm transplantation is not a recognized or established medical procedure in the field of oncology. The term "neoplasm" refers to an abnormal growth of cells, which can be benign or malignant (cancerous). "Transplantation" typically refers to the surgical transfer of living cells, tissues, or organs from one part of the body to another or between individuals.

The concept of neoplasm transplantation may imply the transfer of cancerous cells or tissues from a donor to a recipient, which is not a standard practice due to ethical considerations and the potential harm it could cause to the recipient. In some rare instances, researchers might use laboratory animals to study the transmission and growth of human cancer cells, but this is done for scientific research purposes only and under strict regulatory guidelines.

In summary, there is no medical definition for 'Neoplasm Transplantation' as it does not represent a standard or ethical medical practice.

"Evaluation studies" is a broad term that refers to the systematic assessment or examination of a program, project, policy, intervention, or product. The goal of an evaluation study is to determine its merits, worth, and value by measuring its effects, efficiency, and impact. There are different types of evaluation studies, including formative evaluations (conducted during the development or implementation of a program to provide feedback for improvement), summative evaluations (conducted at the end of a program to determine its overall effectiveness), process evaluations (focusing on how a program is implemented and delivered), outcome evaluations (assessing the short-term and intermediate effects of a program), and impact evaluations (measuring the long-term and broad consequences of a program).

In medical contexts, evaluation studies are often used to assess the safety, efficacy, and cost-effectiveness of new treatments, interventions, or technologies. These studies can help healthcare providers make informed decisions about patient care, guide policymakers in developing evidence-based policies, and promote accountability and transparency in healthcare systems. Examples of evaluation studies in medicine include randomized controlled trials (RCTs) that compare the outcomes of a new treatment to those of a standard or placebo treatment, observational studies that examine the real-world effectiveness and safety of interventions, and economic evaluations that assess the costs and benefits of different healthcare options.

Sensitivity and specificity are statistical measures used to describe the performance of a diagnostic test or screening tool in identifying true positive and true negative results.

* Sensitivity refers to the proportion of people who have a particular condition (true positives) who are correctly identified by the test. It is also known as the "true positive rate" or "recall." A highly sensitive test will identify most or all of the people with the condition, but may also produce more false positives.
* Specificity refers to the proportion of people who do not have a particular condition (true negatives) who are correctly identified by the test. It is also known as the "true negative rate." A highly specific test will identify most or all of the people without the condition, but may also produce more false negatives.

In medical testing, both sensitivity and specificity are important considerations when evaluating a diagnostic test. High sensitivity is desirable for screening tests that aim to identify as many cases of a condition as possible, while high specificity is desirable for confirmatory tests that aim to rule out the condition in people who do not have it.

It's worth noting that sensitivity and specificity are often influenced by factors such as the prevalence of the condition in the population being tested, the threshold used to define a positive result, and the reliability and validity of the test itself. Therefore, it's important to consider these factors when interpreting the results of a diagnostic test.

"Nude mice" is a term used in the field of laboratory research to describe a strain of mice that have been genetically engineered to lack a functional immune system. Specifically, nude mice lack a thymus gland and have a mutation in the FOXN1 gene, which results in a failure to develop a mature T-cell population. This means that they are unable to mount an effective immune response against foreign substances or organisms.

The name "nude" refers to the fact that these mice also have a lack of functional hair follicles, resulting in a hairless or partially hairless phenotype. This feature is actually a secondary consequence of the same genetic mutation that causes their immune deficiency.

Nude mice are commonly used in research because their weakened immune system makes them an ideal host for transplanted tumors, tissues, and cells from other species, including humans. This allows researchers to study the behavior of these foreign substances in a living organism without the complication of an immune response. However, it's important to note that because nude mice lack a functional immune system, they must be kept in sterile conditions and are more susceptible to infection than normal mice.

Organ specificity, in the context of immunology and toxicology, refers to the phenomenon where a substance (such as a drug or toxin) or an immune response primarily affects certain organs or tissues in the body. This can occur due to various reasons such as:

1. The presence of specific targets (like antigens in the case of an immune response or receptors in the case of drugs) that are more abundant in these organs.
2. The unique properties of certain cells or tissues that make them more susceptible to damage.
3. The way a substance is metabolized or cleared from the body, which can concentrate it in specific organs.

For example, in autoimmune diseases, organ specificity describes immune responses that are directed against antigens found only in certain organs, such as the thyroid gland in Hashimoto's disease. Similarly, some toxins or drugs may have a particular affinity for liver cells, leading to liver damage or specific drug interactions.

Equipment design, in the medical context, refers to the process of creating and developing medical equipment and devices, such as surgical instruments, diagnostic machines, or assistive technologies. This process involves several stages, including:

1. Identifying user needs and requirements
2. Concept development and brainstorming
3. Prototyping and testing
4. Design for manufacturing and assembly
5. Safety and regulatory compliance
6. Verification and validation
7. Training and support

The goal of equipment design is to create safe, effective, and efficient medical devices that meet the needs of healthcare providers and patients while complying with relevant regulations and standards. The design process typically involves a multidisciplinary team of engineers, clinicians, designers, and researchers who work together to develop innovative solutions that improve patient care and outcomes.

X-ray computed tomography (CT or CAT scan) is a medical imaging method that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional (tomographic) images (virtual "slices") of the body. These cross-sectional images can then be used to display detailed internal views of organs, bones, and soft tissues in the body.

The term "computed tomography" is used instead of "CT scan" or "CAT scan" because the machines take a series of X-ray measurements from different angles around the body and then use a computer to process these data to create detailed images of internal structures within the body.

CT scanning is a noninvasive, painless medical test that helps physicians diagnose and treat medical conditions. CT imaging provides detailed information about many types of tissue including lung, bone, soft tissue and blood vessels. CT examinations can be performed on every part of the body for a variety of reasons including diagnosis, surgical planning, and monitoring of therapeutic responses.

In computed tomography (CT), an X-ray source and detector rotate around the patient, measuring the X-ray attenuation at many different angles. A computer uses this data to construct a cross-sectional image by the process of reconstruction. This technique is called "tomography". The term "computed" refers to the use of a computer to reconstruct the images.

CT has become an important tool in medical imaging and diagnosis, allowing radiologists and other physicians to view detailed internal images of the body. It can help identify many different medical conditions including cancer, heart disease, lung nodules, liver tumors, and internal injuries from trauma. CT is also commonly used for guiding biopsies and other minimally invasive procedures.

In summary, X-ray computed tomography (CT or CAT scan) is a medical imaging technique that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional images of the body. It provides detailed internal views of organs, bones, and soft tissues in the body, allowing physicians to diagnose and treat medical conditions.

Prostatic neoplasms refer to abnormal growths in the prostate gland, which can be benign or malignant. The term "neoplasm" simply means new or abnormal tissue growth. When it comes to the prostate, neoplasms are often referred to as tumors.

Benign prostatic neoplasms, such as prostate adenomas, are non-cancerous overgrowths of prostate tissue. They usually grow slowly and do not spread to other parts of the body. While they can cause uncomfortable symptoms like difficulty urinating, they are generally not life-threatening.

Malignant prostatic neoplasms, on the other hand, are cancerous growths. The most common type of prostate cancer is adenocarcinoma, which arises from the glandular cells in the prostate. Prostate cancer often grows slowly and may not cause any symptoms for many years. However, some types of prostate cancer can be aggressive and spread quickly to other parts of the body, such as the bones or lymph nodes.

It's important to note that while prostate neoplasms can be concerning, early detection and treatment can significantly improve outcomes for many men. Regular check-ups with a healthcare provider are key to monitoring prostate health and catching any potential issues early on.

Biological models, also known as physiological models or organismal models, are simplified representations of biological systems, processes, or mechanisms that are used to understand and explain the underlying principles and relationships. These models can be theoretical (conceptual or mathematical) or physical (such as anatomical models, cell cultures, or animal models). They are widely used in biomedical research to study various phenomena, including disease pathophysiology, drug action, and therapeutic interventions.

Examples of biological models include:

1. Mathematical models: These use mathematical equations and formulas to describe complex biological systems or processes, such as population dynamics, metabolic pathways, or gene regulation networks. They can help predict the behavior of these systems under different conditions and test hypotheses about their underlying mechanisms.
2. Cell cultures: These are collections of cells grown in a controlled environment, typically in a laboratory dish or flask. They can be used to study cellular processes, such as signal transduction, gene expression, or metabolism, and to test the effects of drugs or other treatments on these processes.
3. Animal models: These are living organisms, usually vertebrates like mice, rats, or non-human primates, that are used to study various aspects of human biology and disease. They can provide valuable insights into the pathophysiology of diseases, the mechanisms of drug action, and the safety and efficacy of new therapies.
4. Anatomical models: These are physical representations of biological structures or systems, such as plastic models of organs or tissues, that can be used for educational purposes or to plan surgical procedures. They can also serve as a basis for developing more sophisticated models, such as computer simulations or 3D-printed replicas.

Overall, biological models play a crucial role in advancing our understanding of biology and medicine, helping to identify new targets for therapeutic intervention, develop novel drugs and treatments, and improve human health.

Brain neoplasms, also known as brain tumors, are abnormal growths of cells within the brain. These growths can be benign (non-cancerous) or malignant (cancerous). Benign brain tumors typically grow slowly and do not spread to other parts of the body. However, they can still cause serious problems if they press on sensitive areas of the brain. Malignant brain tumors, on the other hand, are cancerous and can grow quickly, invading surrounding brain tissue and spreading to other parts of the brain or spinal cord.

Brain neoplasms can arise from various types of cells within the brain, including glial cells (which provide support and insulation for nerve cells), neurons (nerve cells that transmit signals in the brain), and meninges (the membranes that cover the brain and spinal cord). They can also result from the spread of cancer cells from other parts of the body, known as metastatic brain tumors.

Symptoms of brain neoplasms may vary depending on their size, location, and growth rate. Common symptoms include headaches, seizures, weakness or paralysis in the limbs, difficulty with balance and coordination, changes in speech or vision, confusion, memory loss, and changes in behavior or personality.

Treatment for brain neoplasms depends on several factors, including the type, size, location, and grade of the tumor, as well as the patient's age and overall health. Treatment options may include surgery, radiation therapy, chemotherapy, targeted therapy, or a combination of these approaches. Regular follow-up care is essential to monitor for recurrence and manage any long-term effects of treatment.

The brain is the central organ of the nervous system, responsible for receiving and processing sensory information, regulating vital functions, and controlling behavior, movement, and cognition. It is divided into several distinct regions, each with specific functions:

1. Cerebrum: The largest part of the brain, responsible for higher cognitive functions such as thinking, learning, memory, language, and perception. It is divided into two hemispheres, each controlling the opposite side of the body.
2. Cerebellum: Located at the back of the brain, it is responsible for coordinating muscle movements, maintaining balance, and fine-tuning motor skills.
3. Brainstem: Connects the cerebrum and cerebellum to the spinal cord, controlling vital functions such as breathing, heart rate, and blood pressure. It also serves as a relay center for sensory information and motor commands between the brain and the rest of the body.
4. Diencephalon: A region that includes the thalamus (a major sensory relay station) and hypothalamus (regulates hormones, temperature, hunger, thirst, and sleep).
5. Limbic system: A group of structures involved in emotional processing, memory formation, and motivation, including the hippocampus, amygdala, and cingulate gyrus.

The brain is composed of billions of interconnected neurons that communicate through electrical and chemical signals. It is protected by the skull and surrounded by three layers of membranes called meninges, as well as cerebrospinal fluid that provides cushioning and nutrients.

I believe there may be some confusion in your question. "Rabbits" is a common name used to refer to the Lagomorpha species, particularly members of the family Leporidae. They are small mammals known for their long ears, strong legs, and quick reproduction.

However, if you're referring to "rabbits" in a medical context, there is a term called "rabbit syndrome," which is a rare movement disorder characterized by repetitive, involuntary movements of the fingers, resembling those of a rabbit chewing. It is also known as "finger-chewing chorea." This condition is usually associated with certain medications, particularly antipsychotics, and typically resolves when the medication is stopped or adjusted.

Reproducibility of results in a medical context refers to the ability to obtain consistent and comparable findings when a particular experiment or study is repeated, either by the same researcher or by different researchers, following the same experimental protocol. It is an essential principle in scientific research that helps to ensure the validity and reliability of research findings.

In medical research, reproducibility of results is crucial for establishing the effectiveness and safety of new treatments, interventions, or diagnostic tools. It involves conducting well-designed studies with adequate sample sizes, appropriate statistical analyses, and transparent reporting of methods and findings to allow other researchers to replicate the study and confirm or refute the results.

The lack of reproducibility in medical research has become a significant concern in recent years, as several high-profile studies have failed to produce consistent findings when replicated by other researchers. This has led to increased scrutiny of research practices and a call for greater transparency, rigor, and standardization in the conduct and reporting of medical research.

Peptides are short chains of amino acid residues linked by covalent bonds, known as peptide bonds. They are formed when two or more amino acids are joined together through a condensation reaction, which results in the elimination of a water molecule and the formation of an amide bond between the carboxyl group of one amino acid and the amino group of another.

Peptides can vary in length from two to about fifty amino acids, and they are often classified based on their size. For example, dipeptides contain two amino acids, tripeptides contain three, and so on. Oligopeptides typically contain up to ten amino acids, while polypeptides can contain dozens or even hundreds of amino acids.

Peptides play many important roles in the body, including serving as hormones, neurotransmitters, enzymes, and antibiotics. They are also used in medical research and therapeutic applications, such as drug delivery and tissue engineering.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

Monoclonal antibodies are a type of antibody that are identical because they are produced by a single clone of cells. They are laboratory-produced molecules that act like human antibodies in the immune system. They can be designed to attach to specific proteins found on the surface of cancer cells, making them useful for targeting and treating cancer. Monoclonal antibodies can also be used as a therapy for other diseases, such as autoimmune disorders and inflammatory conditions.

Monoclonal antibodies are produced by fusing a single type of immune cell, called a B cell, with a tumor cell to create a hybrid cell, or hybridoma. This hybrid cell is then able to replicate indefinitely, producing a large number of identical copies of the original antibody. These antibodies can be further modified and engineered to enhance their ability to bind to specific targets, increase their stability, and improve their effectiveness as therapeutic agents.

Monoclonal antibodies have several mechanisms of action in cancer therapy. They can directly kill cancer cells by binding to them and triggering an immune response. They can also block the signals that promote cancer growth and survival. Additionally, monoclonal antibodies can be used to deliver drugs or radiation directly to cancer cells, increasing the effectiveness of these treatments while minimizing their side effects on healthy tissues.

Monoclonal antibodies have become an important tool in modern medicine, with several approved for use in cancer therapy and other diseases. They are continuing to be studied and developed as a promising approach to treating a wide range of medical conditions.

Biological transport refers to the movement of molecules, ions, or solutes across biological membranes or through cells in living organisms. This process is essential for maintaining homeostasis, regulating cellular functions, and enabling communication between cells. There are two main types of biological transport: passive transport and active transport.

Passive transport does not require the input of energy and includes:

1. Diffusion: The random movement of molecules from an area of high concentration to an area of low concentration until equilibrium is reached.
2. Osmosis: The diffusion of solvent molecules (usually water) across a semi-permeable membrane from an area of lower solute concentration to an area of higher solute concentration.
3. Facilitated diffusion: The assisted passage of polar or charged substances through protein channels or carriers in the cell membrane, which increases the rate of diffusion without consuming energy.

Active transport requires the input of energy (in the form of ATP) and includes:

1. Primary active transport: The direct use of ATP to move molecules against their concentration gradient, often driven by specific transport proteins called pumps.
2. Secondary active transport: The coupling of the movement of one substance down its electrochemical gradient with the uphill transport of another substance, mediated by a shared transport protein. This process is also known as co-transport or counter-transport.

High-performance liquid chromatography (HPLC) is a type of chromatography that separates and analyzes compounds based on their interactions with a stationary phase and a mobile phase under high pressure. The mobile phase, which can be a gas or liquid, carries the sample mixture through a column containing the stationary phase.

In HPLC, the mobile phase is a liquid, and it is pumped through the column at high pressures (up to several hundred atmospheres) to achieve faster separation times and better resolution than other types of liquid chromatography. The stationary phase can be a solid or a liquid supported on a solid, and it interacts differently with each component in the sample mixture, causing them to separate as they travel through the column.

HPLC is widely used in analytical chemistry, pharmaceuticals, biotechnology, and other fields to separate, identify, and quantify compounds present in complex mixtures. It can be used to analyze a wide range of substances, including drugs, hormones, vitamins, pigments, flavors, and pollutants. HPLC is also used in the preparation of pure samples for further study or use.

A kidney, in medical terms, is one of two bean-shaped organs located in the lower back region of the body. They are essential for maintaining homeostasis within the body by performing several crucial functions such as:

1. Regulation of water and electrolyte balance: Kidneys help regulate the amount of water and various electrolytes like sodium, potassium, and calcium in the bloodstream to maintain a stable internal environment.

2. Excretion of waste products: They filter waste products from the blood, including urea (a byproduct of protein metabolism), creatinine (a breakdown product of muscle tissue), and other harmful substances that result from normal cellular functions or external sources like medications and toxins.

3. Endocrine function: Kidneys produce several hormones with important roles in the body, such as erythropoietin (stimulates red blood cell production), renin (regulates blood pressure), and calcitriol (activated form of vitamin D that helps regulate calcium homeostasis).

4. pH balance regulation: Kidneys maintain the proper acid-base balance in the body by excreting either hydrogen ions or bicarbonate ions, depending on whether the blood is too acidic or too alkaline.

5. Blood pressure control: The kidneys play a significant role in regulating blood pressure through the renin-angiotensin-aldosterone system (RAAS), which constricts blood vessels and promotes sodium and water retention to increase blood volume and, consequently, blood pressure.

Anatomically, each kidney is approximately 10-12 cm long, 5-7 cm wide, and 3 cm thick, with a weight of about 120-170 grams. They are surrounded by a protective layer of fat and connected to the urinary system through the renal pelvis, ureters, bladder, and urethra.

Breast neoplasms refer to abnormal growths in the breast tissue that can be benign or malignant. Benign breast neoplasms are non-cancerous tumors or growths, while malignant breast neoplasms are cancerous tumors that can invade surrounding tissues and spread to other parts of the body.

Breast neoplasms can arise from different types of cells in the breast, including milk ducts, milk sacs (lobules), or connective tissue. The most common type of breast cancer is ductal carcinoma, which starts in the milk ducts and can spread to other parts of the breast and nearby structures.

Breast neoplasms are usually detected through screening methods such as mammography, ultrasound, or MRI, or through self-examination or clinical examination. Treatment options for breast neoplasms depend on several factors, including the type and stage of the tumor, the patient's age and overall health, and personal preferences. Treatment may include surgery, radiation therapy, chemotherapy, hormone therapy, or targeted therapy.

Skovronsky established Avid Radiopharmaceuticals in July 2005 with the goal of finding a dye that could be injected into the ... Avid Radiopharmaceuticals is an American company, founded by Dr. Daniel Skovronsky, and based at the University City Science ... "Avid Radiopharmaceuticals Selected to Receive Seed Funding from BioAdvance; Funds to Be Used to Develop Molecular Imaging Tools ... "Avid Radiopharmaceuticals Initiates First Phase II Trial Of Novel Compound For Imaging Alzheimer's Disease", Medical News Today ...
Radiopharmaceuticals can be used as diagnostic and therapeutic agents. Radiopharmaceuticals emit radiation themselves, which is ... While not all medical isotopes are radioactive, radiopharmaceuticals are the oldest and remain the most common of such drugs. ... There is a section for each radioisotope with a table of radiopharmaceuticals using that radioisotope. The sections are ordered ... Radiopharmaceuticals, or medicinal radiocompounds, are a group of pharmaceutical drugs containing radioactive isotopes. ...
The Journal of Labelled Compounds and Radiopharmaceuticals is a peer-reviewed scientific journal that was established in 1965. ... The Journal of Labelled Compounds and Radiopharmaceuticals is abstracted and indexed in: Aquatic Sciences & Fisheries Abstracts ... Journal of Labelled Compounds and Radiopharmaceuticals. 14 (2): 175. doi:10.1002/jlcr.2580140204. Haka, Michael S.; Kilbourn, ... Journal of Labelled Compounds and Radiopharmaceuticals. 23 (5): 455. doi:10.1002/jlcr.2580230502. "Journals Ranked by Impact: ...
Labelled OIH has a significantly higher clearance than other radiopharmaceutical yet developed and is eminently suitable for ... Testa HJ (22 October 2013). "Radiopharmaceuticals". In O'Reilly PH, Shields RA, Testa HJ (eds.). Nuclear Medicine in Urology ... and for many years this was the only radiopharmaceutical for renography. 131I has a half-life of 8 days and emits high-energy γ ...
"Radiopharmaceuticals". The International Pharmacopoeia (6th ed.). WHO. 2016. IAEA (2007). "Annex II Radiopharmaceuticals: ... Radiopharmaceuticals are generally not designed to have a therapeutic effect themselves, but there is a risk to staff from ... PET radiopharmaceuticals are now often produced by automated computer controlled systems to reduce complexity and radiation ... They prepare and dispense radiopharmaceuticals as unit doses that are then delivered to the subscriber hospital by nuclear ...
Volkert, Wynn A.; Timothy J. Hoffman (1999). "Therapeutic Radiopharmaceuticals". Chemical Reviews. 99 (9): 2269-2292. doi: ... "68Ga-labeled DOTA-Peptides and 68Ga-labeled Radiopharmaceuticals for Positron Emission Tomography: Current Status of Research, ...
Current Radiopharmaceuticals. 9 (2): 114-120. doi:10.2174/1874471009999160625105340. PMID 27593254. Mariani, Giuliano; Giuliano ... locate the draining lymph nodes or sentinel lymph node from a breast cancer tumour a Technetium-99m based radiopharmaceutical ...
Schwochau, K. (2000). Technetium: Chemistry and Radiopharmaceutical Applications. Weinheim, Germany: Wiley-VCH. ISBN 978-3-527- ... Alberto, Roger (2010). "Organometallic Radiopharmaceuticals". Medicinal Organometallic Chemistry. Topics in Organometallic ... "Technetium and Gallium Derived Radiopharmaceuticals: Comparing and Contrasting the Chemistry of Two Important Radiometals for ...
Haddad, Ferid; Barbet, Jacques; Chatal, Jean-Francois (1 July 2011). "The ARRONAX Project". Current Radiopharmaceuticals. 4 (3 ... appropriate radionuclides can be chemically bound to a targeting biomolecule which carries the combined radiopharmaceutical to ...
This is a type of targeted therapy which uses the physical, chemical and biological properties of the radiopharmaceutical to ... Goyal, Jatinder; Antonarakis, Emmanuel S. (October 2012). "Bone-targeting radiopharmaceuticals for the treatment of prostate ... Volkert, Wynn A.; Hoffman, Timothy J. (1999). "Therapeutic Radiopharmaceuticals". Chemical Reviews. 99 (9): 2269-2292. doi: ... Current Radiopharmaceuticals. 5 (3): 221-227. doi:10.2174/1874471011205030221. PMID 22642390. (CS1 errors: generic name, ...
2017 Analytical control of radiopharmaceuticals, IAEA, Vienna (1970) Radioisotopes Production and Quality Control, STI/PUB/10/ ... Surat Chairperson of Radiopharmaceuticals Committee RPC from its inception in 1967 to 1987 Iya played a key role in the ... radio-pharmaceuticals; industrial applications of radiation and radio-tracers; radiation processing of materials and medical ... 128, IAEA, Vienna (1971) Radiopharmaceuticals from generator produced radionuclides, STI/PUB/294, IAEA, Vienna (1971) ...
Robertson, A. K. H.; Ramogida, C. F.; Schaffer, P.; Radchenko, V. (2018). "Development of 225Ac radiopharmaceuticals: TRIUMF ... Current Radiopharmaceuticals. 4 (4): 306-320. doi:10.2174/1874471011104040306. PMC 5565267. PMID 22202153. (Articles with short ... clinical trials have demonstrated the applicability of radiopharmaceuticals containing 225Ac to treat various types of cancer. ... perspectives and experiences". Current Radiopharmaceuticals. 11 (3): 156-172. doi:10.2174/1874471011666180416161908. PMC ...
Current Radiopharmaceuticals, 3, 68-80. 20.) Ido T, Wan CN, Casella V, Fowler JS, Wolf AP, Reivich M, and Kuhl DE (1978). " ... CS1 maint: multiple names: authors list, Radiopharmaceuticals, Halogenation reactions). ...
More than 50 common radiopharmaceuticals are based on technetium-99m for imaging and functional studies of the brain, heart ... ISBN 978-0-8493-0485-9. Schwochau, K. (2000). Technetium: Chemistry and Radiopharmaceutical Applications. Weinheim, Germany: ... Alberto, Roger (2010). "Organometallic Radiopharmaceuticals". Medicinal Organometallic Chemistry. Topics in Organometallic ... "Technetium and Gallium Derived Radiopharmaceuticals: Comparing and Contrasting the Chemistry of Two Important Radiometals for ...
A technetium-99m based radiopharmaceutical kit is also available. Octreotide scanning is reported to have a sensitivity between ... The indium-111 pentetreotide radiopharmaceutical is prepared from a kit in a radiopharmacy. Pentetreotide is a DTPA conjugate ... Current Radiopharmaceuticals. 13 (3): 166-176. doi:10.2174/1874471013666191230143610. PMC 8193811. PMID 31886756. Garai I, ...
Current Radiopharmaceuticals. 9 (1): 19-32. doi:10.2174/1874471008666150313111633. PMID 25771368. Arnold, K.J.; Kaewuam, R.; ... Current Radiopharmaceuticals. 9 (1): 85-93. doi:10.2174/1874471008666150313112620. PMID 25771367. Carollo, A.; Papi, S.; Chinol ...
As a radiopharmaceutical compound that is selective for somatostatin receptors, there is research being done to for these ... There are also some non-radiopharmaceutical compounds that are developed as competitive inhibitors of somatostatin, such as the ... Fani, Melpomeni (2016-12-27), "Current and Future Radiopharmaceuticals in Neuroendocrine Tumor Imaging", Diagnostic and ... Implications for Radiopharmaceutical Therapy". Journal of Nuclear Medicine. 57 (5): 759-764. doi:10.2967/jnumed.115.170423. hdl ...
A person who is being treated for cancer by means of a radiopharmaceutical where a radioisotope is used as a drug (usually a ... Wynn, Volkert; Hoffman, Timothy (1999). "Therapeutic Radiopharmaceuticals". Chemical Reviews (Review article). ACS Publications ...
As a radiopharmaceutical compound that is selective for somatostatin receptors, there is research being done for these ... Some non-radiopharmaceutical compounds that are developed as competitive inhibitors of somatostatin, such as the hormone ... Fani, Melpomeni (2016-12-27), "Current and Future Radiopharmaceuticals in Neuroendocrine Tumor Imaging", Diagnostic and ... Implications for Radiopharmaceutical Therapy". Journal of Nuclear Medicine. 57 (5): 759-764. doi:10.2967/jnumed.115.170423. hdl ...
More than 50 common radiopharmaceuticals are based on technetium-99m for imaging and functional studies of the brain, heart ... ISBN 978-0-8493-0485-9. Schwochau, K. (2000). Technetium: Chemistry and Radiopharmaceutical Applications. Weinheim, Germany: ... Alberto, Roger (2010). "Organometallic Radiopharmaceuticals". Medicinal Organometallic Chemistry. Topics in Organometallic ... "Technetium and Gallium Derived Radiopharmaceuticals: Comparing and Contrasting the Chemistry of Two Important Radiometals for ...
Pauwels EK, Kairemo K, Erba P, Bergström K (January 2010). "Nanoparticles in cancer". Current Radiopharmaceuticals. 1 (1): 30- ...
Vaidyanathan, G.; Zalutsky, M. R. (2008). "Astatine Radiopharmaceuticals: Prospects and Problems". Current Radiopharmaceuticals ... Barbet, J.; Bourgeois, M.; Chatal, J. (2014). "Cyclotron-Based Radiopharmaceuticals for Nuclear Medicine Therapy". In R. P.; ... Guérard, F.; Gestin, J.-F.; Brechbiel, M. W. (2013). "Production of [211At]-Astatinated Radiopharmaceuticals and Applications ... Current Radiopharmaceuticals. 4 (3): 177-185. doi:10.2174/1874471011104030177. PMC 3503149. PMID 22201707. Zuckerman, J. J.; ...
Current Radiopharmaceuticals. 6 (1): 20-7. doi:10.2174/1874471011306010004. PMC 3624777. PMID 23256748. v t e v t e (Articles ... Radiopharmaceuticals, Lutetium complexes, All stub articles, Antineoplastic and immunomodulating drug stubs, Monoclonal ...
Radiopharmaceuticals. 18 (1): 17-26. doi:10.1089/108497803321269296. PMID 12667305. Sakamoto N, Chastain PD, Parniewski P, ...
Radiopharmaceuticals. 25 (6): 705-12. doi:10.1089/cbr.2010.0786. PMID 21204765. Anguiano-Hernandez YM, Chartier A, Huerta S ( ...
Radiopharmaceuticals. 21 (2): 88-100. doi:10.1089/cbr.2006.21.88. PMID 16706629. Chester, Kerry A.; Mayer, Astrid; Bhatia, ...
Radiopharmaceuticals. 24 (2): 155-61. doi:10.1089/cbr.2009.0627. PMC 2902227. PMID 19409036. Janeway CA, Travers P, Walport M, ...
Knapp, Jr., F. F. (Russ) (2016). "2.5 Low-Energy Electron Emitters". Radiopharmaceuticals for Therapy. Springer, New Delhi. doi ...
Nuclear medicine Radiopharmaceutical Hydrogen peroxide decomposition DTPA in chlorine-free Kraft pulping Anonymous Pentetic ... Radiopharmaceuticals. 14 (2): 99-111. doi:10.1089/cbr.1999.14.99. PMID 10850293. Liu, Shuang (2008-09-15). "Bifunctional ...
Radiopharmaceuticals. 26 (5): 639-645. doi:10.1089/cbr.2010.0939. PMID 21950555. (Articles without InChI source, Chemical pages ...
Skovronsky established Avid Radiopharmaceuticals in July 2005 with the goal of finding a dye that could be injected into the ... Avid Radiopharmaceuticals is an American company, founded by Dr. Daniel Skovronsky, and based at the University City Science ... "Avid Radiopharmaceuticals Selected to Receive Seed Funding from BioAdvance; Funds to Be Used to Develop Molecular Imaging Tools ... "Avid Radiopharmaceuticals Initiates First Phase II Trial Of Novel Compound For Imaging Alzheimers Disease", Medical News Today ...
Radiopharmaceuticals can be used as diagnostic and therapeutic agents. Radiopharmaceuticals emit radiation themselves, which is ... While not all medical isotopes are radioactive, radiopharmaceuticals are the oldest and remain the most common of such drugs. ... There is a section for each radioisotope with a table of radiopharmaceuticals using that radioisotope. The sections are ordered ... Radiopharmaceuticals, or medicinal radiocompounds, are a group of pharmaceutical drugs containing radioactive isotopes. ...
... Trends Biotechnol. 2003 Feb;21(2):70-3. doi: 10.1016/s0167-7799(02)00032-x. ... These radiopharmaceuticals enabled the efficacy of antibacterial therapy in animals to be monitored. The scintigraphic approach ...
Radiopharmaceutical. A pharmaceutical drug that emits radiation and is used in diagnostic or therapeutic medical procedures. ...
PharmWeb® - Copyright©1994-2016. All rights reserved ...
Radiopharmaceuticals are cancer drugs that contain radioactive materials. They target cancer cells, giving off radiation that ... How radiopharmaceuticals work. Radiopharmaceuticals are injected into a vein and given in a single dose. They travel to areas ... Radiopharmaceuticals for bone pain. Radiopharmaceuticals are often used to relieve pain from tumors that have spread to the ... Sometimes, radiopharmaceuticals are used with external radiation therapy. The external radiation therapy would be aimed at the ...
"The last mile is the final step in the radiopharmaceutical supply chain," said Belcher. "Its where the radiopharmaceuticals ... The Supply and Availability of Radiopharmaceuticals. Article-The Supply and Availability of Radiopharmaceuticals. ... Radiopharmaceuticals can be administered orally, intravenously, or by inhalation.. "One of the most common uses of ... Radiopharmaceuticals are designed to bind to specific molecules on cancer cells, allowing physicians to identify and locate the ...
Radiopharmaceutical - a radioactive pharmaceutical, nuclide, or other chemical used for diagnostic or therapeutic purposes, is ... Medical Word - Radiopharmaceutical. Ans : a radioactive pharmaceutical, nuclide, or other chemical used for diagnostic or ... Radiopharmaceutical - Glossary. Written & Compiled by Medindia Content Team. Medically Reviewed by The Medindia Medical Review ...
Current Radiopharmaceuticals publishes studies related to nuclear medicine, molecular imaging, radiotherapy, neuroradiology, ...
Radiopharmaceuticals for Sentinel Lymph Node Detection: Status and Trends. Radioisotopes and Radiopharmaceuticals Series No. 6 ... Radioisotopes and Radiopharmaceuticals Reports (1) Apply Radioisotopes and Radiopharmaceuticals Reports filter * (0) Apply ... Diagnostic radiopharmaceuticals (1) Apply Diagnostic radiopharmaceuticals filter *Radionuclide therapy (1) Apply Radionuclide ... Remove Radioisotopes and Radiopharmaceuticals Series filter Radioisotopes and Radiopharmaceuticals Series. *TECDOC Series (4) ...
Radiopharmaceuticals are grouped according to their radioactive decay period. Radiopharmaceuticals are divided into two ... Substance types Radiopharmaceuticals are grouped according to their radioactive decay period Radiopharmaceuticals are divided ... One group comprises radiopharmaceuticals with a half-life equal to or less than two hours. The products do not expire within ... One group comprises radiopharmaceuticals with a half-life equal to or less than two hours. The products do not expire within ...
Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns George Sgouros, Yuni K. Dewaraja, Freddy Escorcia ... Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources Jacek Capala, Stephen A. Graves, Aaron ... Marshalling the Potential of Auger Electron Radiopharmaceutical Therapy Julie Bolcaen, Mohamed A. Gizawy, Samantha Y.A. Terry, ... Dosimetry in Clinical Radiopharmaceutical Therapy of Cancer: Practicality Versus Perfection in Current Practice Neeta Pandit- ...
We provide secure, cost-effective access to the UKs richest collection of digital content: giving you access to the latest data and content from leading international publishers and providers.. Find out more at jisc.ac.uk. ...
Monitoring radioactive gases in effluents from facilities producing positron emitting radionuclides and radiopharmaceuticals ... Monitoring radioactive gases in effluents from facilities producing positron emitting radionuclides and radiopharmaceuticals. ... in the gaseous effluent discharge from facilities producing positron emitting radionuclides and radiopharmaceuticals. Such ...
2022-2029 Global Radiopharmaceuticals Market - 2022-2029 Market Overview Radiopharmaceuticals Market size was valued at USD ... Global Radiopharmaceuticals Market - 2022-2029. Market Overview. Radiopharmaceuticals Market size was valued at USD 6,242.80 ... Market Research Life Sciences Market Research Diagnostics Market Research Medical Imaging Market Research Radiopharmaceuticals ... Global Radiopharmaceuticals market- DataM 14.1. Appendix. 14.2. About Us and Services. 14.3. Contact Us ...
18 million over the next three years to build Calgarys first cyclotron and a new radiopharmaceutical facility. The funding is ... The Edmonton Radiopharmaceutical Centre provides radiopharmaceuticals for clinical use in patients in Edmonton and across ... The Edmonton Radiopharmaceutical Centre at the Cross Cancer Institute is moving to the new Medical Isotope and Cyclotron ... Radiopharmaceuticals are important agents used to diagnose some medical conditions and treat certain diseases. The radioactive ...
Radiopharmaceuticals help CCRI team discover, treat prostate cancer ... Other radiopharmaceutical drugs used for different scans may require an hour or more to circulate within the patients body ... Green said he likes other attributes of the radiopharmaceutical:. • Its fast. Patients are placed on the PET/CT table, ... Radiopharmaceuticals help CCRI team discover, treat prostate cancer. Published on Thursday, August 1, 2019 ...
... to sell more radiopharmaceuticals, according to a False Claims Act lawsuit. ... Cardinal, which operates one of the largest radiopharmaceutical networks with 163 radiopharmacies across the country, has been ... Cardinal Health allegedly paid kickbacks to veteran-owned small businesses to sell more radiopharmaceutical products, according ... UPPI, which represents nearly 90 radiopharmaceutical manufacturers, is seeking damages for other service-disabled and veteran- ...
This guideline describes the additional information that needs to be submitted in relation to radiopharmaceuticals, in the ... This guideline describes the additional information that needs to be submitted in relation to radiopharmaceuticals, in the ...
This training/webinar cannot be booked. To find alternative dates for this training/webinar or similar events please see the events list by topic.. For many training courses and webinars, there are also recordings you can order and watch any time. You can find these recordings in a list sorted by topic.. Or simply send us your inquiry by using the following contact form. ...
The growth of the overall North American nuclear medicine/radiopharmaceuticals market can be contributed to increasing ... The North American nuclear medicine/radiopharmaceuticals market is poised to reach USD 2.98 Billion by 2020, growing at a CAGR ... The U.S. is also expected to account for the largest share of the North American nuclear medicine/radiopharmaceuticals market. ... The North American nuclear medicine/radiopharmaceuticals market is poised to reach USD 2.98 Billion by 2020, growing at a CAGR ...
This report covers the physics of medical cyclotrons and radiopharmaceutical production. It considers the installation, ... Report 105 Medical Cyclotrons (Including PET Radiopharmaceutical Production). Published Institute of Physics & Engineering In ... This report covers the physics of medical cyclotrons and radiopharmaceutical production. It considers the installation, ... the report continues with substantial in-depth chapters on the physics of cyclotrons and radiopharmaceutical production. This ...
Keywords: Radiopharmaceuticals, radionuclide, kit for radiopharmaceutical preparation, core summary of product characteristics ... Core summary of product characteristics for Radiopharmaceuticals (PDF/89.8 KB) First published: 29/07/2010 Last updated: 29/07/ ... Guideline on core summary of product characteristics and package leaflet for radiopharmaceuticals (PDF/343.37 KB) Adopted. ... Draft guideline on core summary of product characteristics and package leaflet for radiopharmaceuticals (PDF/277.44 KB) Draft: ...
302 Pages Report] Radiopharmaceuticals Market is expected to surpass the value of US$ 8.5 Bn by 2031, expanding at a CAGR of ... which are radiopharmaceutical preparation, radionuclide generator, radiopharmaceutical precursor, and radiopharmaceutical ... Global Radiopharmaceuticals Market Attractiveness Analysis, by End-user. 10. Global Radiopharmaceuticals Market Analysis and ... Radiopharmaceuticals Market - Segmentation. TMRs study on the global radiopharmaceuticals market includes information divided ...
project Radiopharmaceutical therapy is a new and underused cancer therapy modalityClinical trials of RPTagents require and ... Radiopharmaceutical therapyRPTis an emerging cancer treatment that delivers radiation directly to cancer. cellsThe recent FDA ... Development and Validation of a Collaborative Web-Based Quantitative Imaging and Dosimetry System for Radiopharmaceutical ...
Radiopharmaceutical tracers for cardiac imaging. Cardiovascular disease (CVD) is the leading cause of death and disease burden ... Several radiopharmaceutical tracers have recently been developed to evaluate CVD by targeting myocardial perfusion, metabolism ... Healthcare QuickLinks: New SPECT guidelines, radiopharmaceutical tracers for cardiac imaging, and more. ...
Radiopharmaceuticals: Radiation Therapy Enters the Molecular Age. The beyond twenty years have brought an ocean change in the ...
  • The growth of the overall North American nuclear medicine/radiopharmaceuticals market can be contributed to increasing preference for SPECT and PET scans, alpha radio immunotherapy-based targeted cancer treatment, advances in radiotracers, growing incidence of cancer and CVDs, and rising awareness about the effective use of radiopharmaceuticals. (prsync.com)
  • The diagnostic type radiopharmaceutical segment is further sub-segmented into SPECT radiopharmaceutical and PET radiopharmaceutical. (medgadget.com)
  • The SPECT radiopharmaceutical segment is further sub-segmented into Technetium-99m, Thallium-201, Iodine-123, and others. (medgadget.com)
  • Advancement in the industry has brought about advent of technologies such as PET and SPECT scans which further broadens reach of radiopharmaceuticals. (bharatbook.com)
  • The purpose of this guideline is to assist nuclear medicine practitioners in recommending, performing, interpreting, and reporting the results of brain perfusion SPECT studies using 99m Tc radiopharmaceuticals. (snmjournals.org)
  • SPECT of the brain is a technique for obtaining tomographic images of the 3-dimensional distribution of a radiopharmaceutical, which reflects regional cerebral perfusion. (snmjournals.org)
  • The Global Radiopharmaceutical Market is expected to grow at a CAGR of 8.7% during the forecast period 2017-2023. (medgadget.com)
  • The appearance of COVID-19 considerably impacted the global radiopharmaceuticals market. (marketresearch.com)
  • On the basis of end-use application, the global radiopharmaceuticals market is divided into two different types, including diagnostic centers and hospitals. (transparencymarketresearch.com)
  • The global radiopharmaceuticals market is driven by the rise in patient awareness, demand for precise diagnosis, increasing demand for disease-targeted cancer therapy, and the growing uses of molecular imaging. (transparencymarketresearch.com)
  • In 2020, the global radiopharmaceuticals market was headed by North America, trailed by Europe. (transparencymarketresearch.com)
  • These radiopharmaceuticals enabled the efficacy of antibacterial therapy in animals to be monitored. (nih.gov)
  • Advanced radiation therapy delivered with compassion, Radiopharmaceuticals are one of the advanced radiation therapy treatments available at Cooper - delivered with compassion. (cooperhealth.org)
  • For cancer that has spread to more than one bone, radiopharmaceuticals work better than external radiation therapy. (cooperhealth.org)
  • Sometimes, radiopharmaceuticals are used with external radiation therapy. (cooperhealth.org)
  • However, the disadvantages of radiopharmaceutical therapy include radiation risks, images that are not usually disease-specific, in this therapy typically requiring injection into the bloodstream, disposal of radioactivity waste and high cost of the treatment. (marketresearch.com)
  • In 2022 situation is recovering from COVID-19, and the patient can access the proper treatments, leading to market growth of radiopharmaceutical therapy worldwide. (marketresearch.com)
  • Also, as per the article published in Nature Reviews Drug Discovery in July 2020, several radiopharmaceutical therapy (RPT) agents are currently on the market, with many more in development. (marketresearch.com)
  • The quantity of radiation in diagnostic radiopharmaceuticals is lower than in therapy radiopharmaceuticals. (transparencymarketresearch.com)
  • The utilization of monoclonal antibodies and radiolabeled peptides for the identification and treatment of malignant tumors (referred to as radiopharmaceutical-based customized therapy) is likely to fuel the growth of the global market for radiopharmaceuticals. (transparencymarketresearch.com)
  • Demand for radiopharmaceuticals is growing due to raising awareness about availability of radiation and radioisotopes in medicine, particularly for diagnosis and therapy for various chronic conditions. (medgadget.com)
  • en] Radiopharmaceuticals are used in nuclear medicine for diagnosis and therapy. (iaea.org)
  • OPAQ-PF, in massive with all smooth Confirmatory PRO months, may be more similar download radiopharmaceuticals for therapy when shared in a site with a collaboration of item than when been in a bully without important south. (mcnamara-law.com)
  • only, the Con Programming download radiopharmaceuticals for therapy from Constellation in Lincoln, also, April 13-15 fell me my plan resurrection. (mcnamara-law.com)
  • The United States ventured a righteous download radiopharmaceuticals for therapy in the planet and dosing of that experience. (mcnamara-law.com)
  • Radiopharmaceuticals can be used as diagnostic and therapeutic agents. (wikipedia.org)
  • The large share and high growth in the U.S. can be attributed to the focus on domestic production of Mo-99, the approval of new radiopharmaceuticals by the FDA in the U.S., FDA approval for alpha emitter, growing focus on therapeutic nuclear medicine as an alternative treatment in oncology, and growing incidence of thyroid cancer. (prsync.com)
  • The North American nuclear medicine/radiopharmaceuticals market comprises of diagnostic and therapeutic radioisotopes. (prsync.com)
  • Radiopharmaceuticals are a class of radioactive substances that can be employed for diagnostic or therapeutic purposes. (transparencymarketresearch.com)
  • Radiopharmaceuticals are basically unique therapeutic compositions that incorporate radioisotopes. (transparencymarketresearch.com)
  • By type, the market for radiopharmaceutical is segmented into diagnostic type radiopharmaceuticals and therapeutic type radiopharmaceuticals. (medgadget.com)
  • The therapeutic type radiopharmaceutical segment is further sub-segmented into beta emitters, alpha emitters, brachytherapy. (medgadget.com)
  • Sparke's "Mission" is the research and development of radiopharmaceuticals to implement new diagnostic and therapeutic strategies, to improve patient life expectancy and quality of life. (comecer.com)
  • Copper radiopharmaceuticals revolutionise nuclear medicine with advanced diagnostic and therapeutic applications, particularly in oncology and cardiology. (openmedscience.com)
  • Copper radiopharmaceuticals represent a fascinating and rapidly evolving area in the field of nuclear medicine , leveraging the unique properties of copper isotopes in diagnostic imaging and therapeutic applications. (openmedscience.com)
  • A Phase 1, Open-label, Dose-Ascending Study to Evaluate the Safety and Tolerability of the Therapeutic Radiopharmaceutical 131I-MIP-1095 for the Treatment of Metastatic Castration-Resistant Prostate Cancer. (bvsalud.org)
  • Radiopharmaceuticals are classified into four different categories, which are radiopharmaceutical preparation, radionuclide generator, radiopharmaceutical precursor, and radiopharmaceutical preparation kit. (transparencymarketresearch.com)
  • They allow the calculation of the activity releases, in the gaseous effluent discharge from facilities producing positron emitting radionuclides and radiopharmaceuticals. (iso.org)
  • Gay is among patients most likely to benefit from the testing that uses a radiopharmaceutical and a positron emission tomography/computed tomography, or PET/CT, scan. (umc.edu)
  • Developing radiosynthesis methods and creating the quality standard for radiopharmaceuticals based on cyclotron and generator-produced positron-emitting isotopes. (almazovcentre.ru)
  • Based on product type, the radiopharmaceutical theranostics market is segmented into positron emission tomography (PET) tracers, beta emitters, and alpha emitters. (theinsightpartners.com)
  • The assessment of myocardial perfusion and function using PET and hybrid positron emission tomography (PET)/CT imaging is becoming more available as the cost of the technology decreases and as positron-emitting radiopharmaceuticals become more available. (medscape.com)
  • Avid Radiopharmaceuticals is an American company, founded by Dr. Daniel Skovronsky, and based at the University City Science Center research campus in Philadelphia, Pennsylvania. (wikipedia.org)
  • Dr. Skovronsky established Avid Radiopharmaceuticals in July 2005 with the goal of finding a dye that could be injected into the body, would cross the blood-brain barrier and attach itself to amyloid protein deposits in the brain. (wikipedia.org)
  • Dosimetry for these radiopharmaceuticals is presented in Tables 1 and 2 . (snmjournals.org)
  • CALGARY - Alberta is committing more than $18 million over the next three years to build Calgary's first cyclotron and a new radiopharmaceutical facility. (canhealth.com)
  • The Calgary cyclotron will also begin developing novel radiopharmaceuticals with very short half-lives of less than 20 minutes, since they can be used and studied immediately. (canhealth.com)
  • A cyclotron in Calgary will improve access to a wide variety of diagnostic products as we will be able produce the radiopharmaceuticals on site. (canhealth.com)
  • While the exact location of the new cyclotron and radiopharmaceutical facility is still being finalized, initial planning steps have been completed. (canhealth.com)
  • Radiopharmaceuticals are cancer drugs that contain radioactive materials. (cooperhealth.org)
  • Radiopharmaceuticals are biological compounds that contain radioactive isotopes. (mddionline.com)
  • Radiopharmaceuticals contain radioactive substances used to diagnose or treat diseases, including cancer or cardiology. (marketresearch.com)
  • A list of nuclear medicine radiopharmaceuticals follows. (wikipedia.org)
  • Its production chain depends largely on imported radioisotopes-radioactive substances manufactured in nuclear reactors that serve as the raw material for radiopharmaceuticals. (fapesp.br)
  • One of the reactor's limitations is that it does not have the capacity to mass produce molybdenum-99, the raw material of radiopharmaceutical technetium-99m, used in 80% of nuclear medical procedures performed in the country. (fapesp.br)
  • The North American nuclear medicine/radiopharmaceuticals market is poised to reach USD 2.98 Billion by 2020, growing at a CAGR of 8.6% during the forecast period of 2015 to 2020. (prsync.com)
  • In the coming years, U.S. is expected to witness the highest growth rate in the North American nuclear medicine/radiopharmaceuticals market. (prsync.com)
  • The U.S. is also expected to account for the largest share of the North American nuclear medicine/radiopharmaceuticals market. (prsync.com)
  • The report segments the North American nuclear medicine/radiopharmaceuticals market based on type of isotope. (prsync.com)
  • The diagnostic radioisotopes segment is expected to account for the largest share of the North American nuclear medicine/radiopharmaceuticals market in 2015. (prsync.com)
  • Analysis of key drivers (increasing incidence and prevalence of target conditions, development of alpha-radioimmunotherapy-based targeted cancer treatments, initiatives to reduce the demand and supply gap of Mo-99), restraints (Short half-life of radiopharmaceuticals),opportunities (use of radiopharmaceuticals in neurological applications and high growth opportunities in emerging countries) and challenges (hospital budget cuts and high equipment costs) influencing the growth of nuclear medicine market. (giiresearch.com)
  • The Research Department for Nuclear Medicine and Theranostics together with Radiopharmaceutical Production Department, Radiopharmaceutical Quality Control Department and Radioisotope Imaging/PET Department are comprised in the Nuclear Medicine Research Unit. (almazovcentre.ru)
  • Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which finds applications in clinical areas for diagnostic or therapeutics of human diseases. (bharatbook.com)
  • On September 27, Marcos Pontes, the Minister of Science, Technology, and Innovation (MCTI) told the Brazilian House of Representatives that when the 2021 budget was released, it was immediately clear that it would not cover the demand for radiopharmaceuticals. (fapesp.br)
  • Radiopharmaceuticals Market size was valued at USD 6,242.80 million in 2021 and is estimated to reach a compound annual growth rate (CAGR) of 6.2% over the forecast period 2022 to 2029. (marketresearch.com)
  • 99m Tc is predicted to dominate the global radiopharmaceutical market throughout the forecast timeframe, from 2021 to 20321, as applications of 99m Tc for dynamic and morphological imaging of the liver, kidneys, and bone are expected to rise. (transparencymarketresearch.com)
  • This guideline describes the additional information that needs to be submitted in relation to radiopharmaceuticals, in the context of applications for marketing authorisations or variations to authorised medicinal products. (gmp-compliance.org)
  • Radiopharmaceuticals, or medicinal radiocompounds, are a group of pharmaceutical drugs containing radioactive isotopes. (wikipedia.org)
  • As with other pharmaceutical drugs, there is standardization of the drug nomenclature for radiopharmaceuticals, although various standards coexist. (wikipedia.org)
  • ACIC Pharmaceutical Machinery and our partners have extensive experience in the design and commissioning of state-of-the-art equipment and turnkey solutions for the manufacture of radiopharmaceuticals. (acic.com)
  • As a strong new generation provider in the field of radiopharmaceuticals in China , Sinotau will continue to contribute to innovation in radiopharmaceuticals, accelerate the research and development of urgently needed clinical drugs to better meet the growing clinical needs for diagnosis and treatment," said Xinsheng Xu , Chairman of Sinotau Pharmaceutical Group . (thailand-business-news.com)
  • Bayer is one of several large pharmaceutical companies interested in radiopharmaceuticals, drugs that combine a radioactive particle with a targeting molecule designed to seek out tumors. (biopharmadive.com)
  • According to the National Cancer Institute October 2020 data report, researchers have recently designed and tested radiopharmaceuticals for various cancers as diverse as lung, melanoma, colorectal, and leukemia. (marketresearch.com)
  • Due to a rise in PET- CT scanner equipment installations and increased demand for disease risk assessment services for cancer treatment, North America held a large part of the global market for radiopharmaceuticals in 2020. (transparencymarketresearch.com)
  • Melanoma affine radiopharmaceuticals I. A comparative study of 131I-labeled quinoline and tyrosine derivatives. (curehunter.com)
  • The report offers insights and in-depth analysis of the market, emphasizing parameters such as dynamics, trends, and opportunities prevailing in the radiopharmaceutical theranostics market. (theinsightpartners.com)
  • It also provides the competitive landscape analysis of leading market players in global radiopharmaceutical theranostics market. (theinsightpartners.com)
  • Radiopharmaceuticals are referred to as 'tracers' when they are utilized for diagnostic reasons. (transparencymarketresearch.com)
  • Several radiopharmaceutical tracers have recently been developed to evaluate CVD by targeting myocardial perfusion, metabolism, innervation, and inflammation. (digirad.com)
  • It is obtained on-site at the imaging center as the soluble pertechnetate which is eluted from a technetium-99m generator, and then either used directly as this soluble salt, or else used to synthesize a number of technetium-99m-based radiopharmaceuticals. (wikipedia.org)
  • Newer gamma cameras using simultaneous 180° acquisition appear to have the potential of offering similar benefits as PET technology but are able to use the less costly technetium (TC)-99m-based radiopharmaceuticals and thallium-201 (Tl-201). (medscape.com)
  • online ebook safety and efficacy of radiopharmaceuticals ' history airways always like in request shortages and read Private organization desire to learners across the gap. (apcopetroleum.com)
  • The ebook safety and efficacy of radiopharmaceuticals is due 20 trucks diverse. (apcopetroleum.com)
  • With With an Eye to the Gemini, signed long enabled on February 7, 2001 at a ebook safety and efficacy of radiopharmaceuticals 1983 prevention. (apcopetroleum.com)
  • One of the most common uses of radiopharmaceuticals is in cancer diagnosis and treatment," said RLS CEO Stephen Belcher . (mddionline.com)
  • Radiopharmaceuticals are designed to bind to specific molecules on cancer cells, allowing physicians to identify and locate the tumor. (mddionline.com)
  • The radiopharmaceuticals market growth is driven by the rise in prevalence of different diseases such as cancer, and neurological disorders, rising adoption of radiopharmaceuticals for diagnosis and treatment of diseases, increase in the geriatric population, and research and development activities. (marketresearch.com)
  • Some researchers are now testing radiopharmaceuticals combined with radiation sensitizers-drugs that make cancer cells even more vulnerable to radiation. (marketresearch.com)
  • Green said cancer cells more readily gather the radiopharmaceutical gathers making them more apparent on the images. (umc.edu)
  • Radiopharmaceuticals use radiation to provide diagnostic information about the functioning of a person's specific organs while radiotherapy can be used to treat some medical conditions, especially cancer, used to weaken or destroy particular targeted cells. (medgadget.com)
  • Market demand for radiopharmaceuticals has been consistently progressing due to higher incidences of chronic diseases, prevalence of cancer and other cardiac ailments and increasing awareness of radiopharmaceuticals. (bharatbook.com)
  • The deal gives Bayer exclusive rights to a preclinical radiopharmaceutical targeted at PSMA, a protein commonly found on prostate cancer cells. (biopharmadive.com)
  • The drugmaker has experience with an earlier generation of radioactive cancer treatment - Xofigo, a prostate cancer drug sold by Bayer, consists of radium-223 - and is testing a PSMA-targeted radiopharmaceutical that uses another type of isotope called thorium-227. (biopharmadive.com)
  • Novartis will present data from a large Phase 3 study of a prostate cancer radiopharmaceutical at the American Society of Clinical Oncology virtual meeting over the weekend. (biopharmadive.com)
  • The market research report examines the radiopharmaceutical sector in further depth, offering a comprehensive view of market dynamics, patient preferences, illness trends, and supply and demand. (transparencymarketresearch.com)
  • In fact, growth dynamics of healthcare industry overall moves in conjugation with that of radiopharmaceuticals due to its widespread application in various healthcare domains such as cardiology, oncology, neurology, etc. (bharatbook.com)
  • Cardinal Health allegedly paid kickbacks to veteran-owned small businesses to sell more radiopharmaceutical products, according to a recently unsealed False Claims Act lawsuit. (modernhealthcare.com)
  • The development and distribution of radiopharmaceuticals is highly specialized, and Cardinal Health operates in strict accordance with all applicable state and federal regulations," the company said. (modernhealthcare.com)
  • Without quality and reliable radiopharmaceuticals delivered safely and timely, the full potential of these molecular imaging probes and therapies will not be realized. (mddionline.com)
  • Moreover, using radiopharmaceuticals in combination with other therapies may be one way to drive that improvement. (marketresearch.com)
  • The company offers an extensive portfolio of diagnostic products and has become one of the fastest-growing distributors of radiopharmaceutical therapeutics. (mddionline.com)
  • and Asia Pacific-Japan & China) Outlook 2024" provides information on the current scenario, detailed market outlook of the global radiopharmaceutical market with detailed analysis of market segments such as Diagnostics & Therapeutics. (bharatbook.com)
  • One type of sensor is an electrode coated with a polymer film into which the radiopharmaceutical partitions to enable its detection by voltammetry. (iaea.org)
  • However, the short half-life of radiopharmaceuticals decreases their potential adoption, and are expected to challenge market growth to a certain extent. (giiresearch.com)
  • North America, Latin America, Asia Pacific, Europe, the Middle East, and Africa are the four primary regions that make up the global radiopharmaceuticals business. (transparencymarketresearch.com)
  • At present, about 25 million diagnostic procedures involving 99m Tc radiopharmaceuticals are performed yearly, with trends indicating that this number is likely to rise. (transparencymarketresearch.com)
  • Market Research Future published a cooked research report on "Radiopharmaceutical Market Research Report - By Major Industry Trends, Worldwide Business Analysis, Major Segments and Sub segments. (medgadget.com)
  • Read the full newsletter here to learn about the latest trends in radiopharmaceutical manufacturing. (acic.com)
  • Patel PR , Larson AK , Castel AD , Ganova-Raeva LM , Myers RA , Roup BJ , Hepatitis C virus infections from a contaminated radiopharmaceutical used in myocardial perfusion studies. (cdc.gov)
  • Radiopharmaceuticals can be administered orally, intravenously, or by inhalation . (mddionline.com)
  • Patients are placed on the PET/CT table, intravenously injected with the radiopharmaceutical and scanned within about five minutes. (umc.edu)
  • The radiopharmaceutical is acting as an all-rounder radiopharmaceutical from diagnosis to treatment for various chronic diseases such as cancers and other neurological disorders, which has provided an impetus to the market. (medgadget.com)
  • After passing all tests, these radiopharmaceuticals are transported to hospitals and clinics for the benefit of patients. (mddionline.com)
  • The Federal Trade Commission alleged that Cardinal monopolized 25 markets from 2003 to 2008 for the sale of radiopharmaceuticals to hospitals and clinics. (modernhealthcare.com)
  • While not all medical isotopes are radioactive, radiopharmaceuticals are the oldest and remain the most common of such drugs. (wikipedia.org)
  • These isotopes are then transported to different laboratories worldwide, where they undergo purification to produce radiopharmaceuticals. (mddionline.com)
  • At the end of September, Brazil had to temporarily shut down production of radiopharmaceuticals-drugs containing radioactive elements used to diagnose and treat various diseases in oncology, cardiology, hematology, and neurology. (fapesp.br)
  • Iodine-123 is preferred for imaging, so I-125 is used diagnostically only when the test requires a longer period to prepare the radiopharmaceutical and trace it, such as a fibrinogen scan to diagnose clotting. (wikipedia.org)
  • Malignant and metastatic cells more readily gather the radiopharmaceutical that was injected, making them appear brighter on the digital imaging. (umc.edu)
  • Neuraceq ® (欧韦宁 ® ), an amyloid PET imaging radiotracer, is the first radiopharmaceutical targeting β-amyloid approved in China to be used to support diagnosis of Alzheimer's disease (AD). (thailand-business-news.com)
  • This is demonstrated with an electrochemical sensor that consists of a carbon electrode modified with Nafion gel for [Re(DMPE) 3 ]CF 3 SO 3 , a non-radioactive radiopharmaceutical analog for heart imaging. (iaea.org)
  • Other radiopharmaceutical drugs used for different scans may require an hour or more to circulate within the patient's body before they can be scanned. (umc.edu)
  • The PET radiopharmaceutical segment is further sub-segmented into F-18, Rubidium-82, and others. (medgadget.com)
  • The new Calgary facility will also spark world-class research to discover innovative, next-generation radiopharmaceuticals and radiotracers that can direct and provide medicine precisely to targeted organs or parts of the body, or could help better understand the progression of Alzheimer's or Parkinson's disease. (canhealth.com)
  • In the last few years, there has been a tremendous increase in research activity aimed at developing new and better 99m Tc radiopharmaceuticals. (transparencymarketresearch.com)
  • Developing and implementing the modern radioisotope techniques, new radiopharmaceuticals and software applications for the processing of diagnostic and research data. (almazovcentre.ru)
  • Novartis, in particular, has been active, acquiring the biotech companies Endocyte and Advanced Accelerator Applications and making radiopharmaceuticals a research focus. (biopharmadive.com)
  • In addition, due to their widespread availability and low prices, various radiopharmaceuticals are expected to gain popularity. (transparencymarketresearch.com)
  • The radiopharmaceutical supply chain process represents a complex system involving several crucial steps starting from production, synthesis, quality control, and dispensation to patients. (mddionline.com)
  • UPPI, which represents nearly 90 radiopharmaceutical manufacturers, is seeking damages for other service-disabled and veteran-owned small businesses that were allegedly harmed by the anticompetitive practices. (modernhealthcare.com)
  • There is a section for each radioisotope with a table of radiopharmaceuticals using that radioisotope. (wikipedia.org)
  • The project will allow Calgary to produce its own consistent supply of radiopharmaceuticals - a special class of drug that can help diagnose and treat many types of cancers, bone disease, strokes, epilepsy or dementia. (canhealth.com)
  • As the healthcare industry is moving towards the personalized approaches, the role of radiopharmaceutical is also increasing. (medgadget.com)